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Abstract
Serum-derived granulations and purported nanobacteria (NB) are pleomorphic apatite structures shown to resemble
calcium granules widely distributed in nature. They appear to be assembled through a dual inhibitory-seeding mechanism
involving proteinaceous factors, as determined by protease (trypsin and chymotrypsin) and heat inactivation studies. When
inoculated into cell culture medium, the purified proteins fetuin-A and albumin fail to induce mineralization, but they will
readily combine with exogenously added calcium and phosphate, even in submillimolar amounts, to form complexes that
will undergo morphological transitions from nanoparticles to spindles, films, and aggregates. As a mineralization inhibitor,
fetuin-A is much more potent than albumin, and it will only seed particles at higher mineral-to-protein concentrations. Both
proteins display a bell-shaped, dose-dependent relationship, indicative of the same dual inhibitory-seeding mechanism
seen with whole serum. As ascertained by both seeding experiments and gel electrophoresis, fetuin-A is not only more
dominant but it appears to compete avidly for nanoparticle binding at the expense of albumin. The nanoparticles formed in
the presence of fetuin-A are smaller than their albumin counterparts, and they have a greater tendency to display a multi-
layered ring morphology. In comparison, the particles seeded by albumin appear mostly incomplete, with single walls.
Chemically, spectroscopically, and morphologically, the protein-mineral particles resemble closely serum granules and NB.
These particles are thus seen to undergo an amorphous to crystalline transformation, the kinetics and completeness of
which depend on the protein-to-mineral ratios, with low ratios favoring faster conversion to crystals. Our results point to a
dual inhibitory-seeding, de-repression model for the assembly of particles in supersaturated solutions like serum. The
presence of proteins and other inhibitory factors tend to block apatite nuclei formation or to stabilize the nascent nuclei as
amorphous or semi-crystalline spherical nanoparticles, until the same inhibitory influences are overwhelmed or de-
repressed, whereby the apatite nuclei grow in size to coalesce into crystalline spindles and films—a mechanism that may
explain not only the formation of calcium granules in nature but also normal or ectopic calcification in the body.
Citation: Wu C-Y, Martel J, Young D, Young JD (2009) Fetuin-A/Albumin-Mineral Complexes Resembling Serum Calcium Granules and Putative Nanobacteria:
Demonstration of a Dual Inhibition-Seeding Concept. PLoS ONE 4(11): e8058. doi:10.1371/journal.pone.0008058
Editor: David M. Ojcius, University of California Merced, United States of America
Received September 22, 2009; Accepted November 4, 2009; Published November 30, 2009
Copyright:  2009 Wu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by Primordia Institute of New Sciences and Medicine and by grants from Chang Gung University (FMRPD2T02) and from
Mingchi University of Technology (0XB0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: dingeyoung@hotmail.com
. These authors contributed equally to this work.
Introduction
The experiments reported here represent the continuation of
our studies on the mechanisms by which nanoparticles resembling
the so-called nanobacteria (NB) are formed and by which
anomalous ectopic calcification is triggered [1–3]. NB are
supposed to represent exotic, slow growing, pleomorphic, sub-
micrometer (50–500 nm) microorganisms coated with proteins
and containing carbonate hydroxyapatite (HAP) [4–12]. These
putative microorganisms are deemed identical to the spherical
forms observed earlier by Folk in geological samples and which he
called ‘nannobacteria’ [4,13,14]. The purported NB are ubiqui-
tous, being found not only in soils [13,14], water [15,16], and air
[17], but also in harsh and remote environments like meteorites
[18], stratosphere [19,20], and even interstellar dust [21]. They
are supposedly associated with body fluids [4–12], body infusion
products and vaccines [4,22] and have been described as causative
or aggravating agents of numerous diseases, especially extraskeletal
calcifications ([4–12]; see also ref. [23] for a list of such ectopic
calcifications with a potential link to NB). NB have thus been
implicated in kidney stone formation, calcifications, and polycystic
disorders [5,8,9,11,12,24–27] as well as atherosclerosis and other
cardiovascular calcifications [28–32]. Notably, NB have been
characterized from the outset as infectious agents of disease
[5–12,23]. Thus, while NB are now referred also as calcifying
nanoparticles (CNP)—a term that more appropriately acknowl-
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limitations associated with NB—they continue to be viewed and
heralded as infectious and transmissible agents of anomalous
ectopic calcifications [6,7,10,26–32]. In fact, their infectious
nature has been deemed of cardinal importance not only in the
understanding of their complex and enigmatic biological cycle
[8,9] but also in providing a basis for justifying the use of
antimicrobial therapy regimens to combat supposed NB infections
[33–35]. As agents of transmissible infectivity, NB are said to
fulfill either in part or completely the classic Koch’s postulates
[6–8,28,36–39]. On these same grounds, NB have been proposed
as a potential global health hazard [16,17,40,41]. NB are thus
unusual in that they are seen by some [25] not only as primitive
symbionts and precursors of biological life but also as infectious
agents of disease—extraordinary claims in themselves that have
led to intense debate and skepticism. An extensive list of these and
other claims made by the NB proponents has been presented
earlier [42].
These same views on NB have been refuted on both
epistemological [43] and experimental [1–3,44–46] grounds. Cisar
et al. [44] have provided convincing evidence that challenges the
organismic claims made earlier for NB, indicating instead that NB
represent lifeless HAP complexed with organic compounds;
furthermore, the authors have emphasized the role of lipids like
phosphatidylinositol as nucleators of HAP that in turn can
reproduce the many morphologies associated with NB. Raoult
et al. [46] have reached the conclusion that NB are ‘‘mineralo
fetuin’’ complexes that they have renamed as ‘‘nanons.’’ Both
these groups have described a protein profile associated with the
putative NB grown in serum-free conditions consisting of no more
than a few major bands, the main one being fetuin-A, according to
Raoult et al. [46]. This simple protein profile stands in marked
contrast to the much more complex organismic protein profile that
one would have expected for live bacteria and that had in fact
been published by other groups [7,26]. In Cisar et al. ’s view [44],
the proteins associated with NB grown from the various body
fluids are most likely derived from the direct binding of proteins to
the growing HAP. Moreover, Raoult et al. [46] have shown that
the earlier antibodies marketed as specific for NB, rather than
binding to foreign proteins of microorganismic origin, detect
fetuin-A instead.
Our own studies have sought to reproduce the NB phenom-
enology in its entirety by means of a reductionist approach using
simple calcium compounds like calcium carbonate as well as other
competing ions to reconstitute particles that morphologically
resemble NB [1]. Our results are significant in that they
demonstrate that various calcium compounds may biomimetically
resemble complex biological forms like NB—findings that are
consistent with earlier observations made on geological samples
enriched for calcite, carbonate, and silicate phases [47–50], all of
which are capable of biomimetically resembling living organisms.
These various studies raise caution against the use of morpholog-
ical criteria per se as the sole basis for implicating biological or life-
related activities. In our studies, the initially amorphous calcium
particles were seen in the presence of serum to rapidly bind to
proteins and ions, to acquire phosphate, to crystallize, and to
nucleate further aggregation of HAP [2]. Serum was further
shown to inhibit paradoxically the formation of NB-like precip-
itations, presumably through the binding to calcium and nascent
apatite by calcification inhibitors present in the serum—a
protective mechanism built-in likely to prevent unwanted
calcification [2]. When saturated with calcium phosphate, these
same calcification inhibitors—showing high affinities for calcium,
nascent apatite, or perhaps both—are thought to turn into seeds
for the nucleation of HAP, that upon further phase conversion and
growth, end up mimicking and displaying the many peculiar
characteristics of NB, including most notably their marked
pleomorphism [2]. In our hands, the proteins associated with
the NB scaffold were found to include albumin, complement
components 3 and 4A, fetuin-A, and apolipoproteins A1 and B100
[2,3]. This protein profile appears to mirror the very composition
of the calcium and apatite binding proteins found in the serum
that in turn had been used to culture and assemble NB; their
relative abundance found in the NB scaffold appears to vary
directly with their respective protein concentrations seen in the
feeder serum as well as with their calcium and apatite binding
affinities [2]. Accordingly, in the case of NB formed in the
presence of other body fluids (saliva, urine, ascites, cerebrospinal
fluid, pleural effusion, and synovial fluid), the bound proteins have
also turned out to consist of the most abundant calcium-binding
proteins found in these fluids, including various immunoglobulin
G chains for saliva, and albumin and apolipoprotein A1 for the
other body fluids [2]. The NB protein composition can be further
modulated by changing or removing the source of proteins
comprising the milieu of the nucleating NB, indicating that their
presence in the NB scaffold may be circumstantially determined by
their availability in the surrounding microenvironment and by
their affinity for calcium and apatite [2]. Still in this context, our
own exhaustive proteomic analyses of multiple putative NB
specimens have revealed only common mammalian proteins that
can be entirely explained by the source of serum, body fluid, or
tissue used for culturing NB [2,3], in marked contrast to a more
exotic protein profile claimed earlier for NB and comprising of
prokaryotic proteins like porins and complex peptidoglycans
[5,24] as well as the bacterial translation elongation factor Tu
and the molecular chaperone GroEL [26]. Furthermore, our own
immunoblotting experiments have revealed that both polyclonal
and monoclonal antibodies, previously claimed to be specific for
NB and used in numerous studies to affirm the presence of (and a
pathological implication for) NB in human tissues, in fact bind
strongly to both albumin and fetuin-A from the same as well as
across species [2]. This surprising finding indicates that all the past
immunodetection studies used to implicate a role for NB in human
pathologies may very well have detected either albumin or fetuin-
A, or a combination of both, derived not only from the very fetal
bovine serum (FBS) used for the culture and demonstration of NB,
but possibly also from the human tissue under investigation as well.
This confusing and misleading scenario now needs to be taken into
account when interpreting any past immunodetection study done
to ascertain the presence of NB in human tissues.
Our earlier study indicates that the purported NB can be seen as
consisting essentially of protein-mineral or organic-mineral
complexes formed by means of a dual inhibition-seeding
mechanism involving the binding of proteinaceous and other
organic calcification inhibitors to calcium and nascent apatite
minerals [2]. These inhibitors function presumably within a larger
homeostatic cycle of calcium sequestration and clearance [2].
Subsequent experiments have demonstrated the formation of NB-
resembling calcium granulations (also referred as calcium granules
in the present study) within both fetal bovine and human sera that
had been overloaded with either calcium, phosphate, or a
combination of both; this granular formation appears to be the
result of direct chemical binding between ionic and organic
moieties and it precludes the need for any prolonged incubation
under culture conditions [3] that earlier had been deemed
necessary for the demonstration of NB [4,5]. By means of simple
binding between serum components and calcium and phosphate,
we are now able to demonstrate a plethora of NB-like
Protein-Mineral Nanoparticles
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and even films [3]. This same sequestration of calcium in the form
of calcium granules is known to occur throughout nature as part of
a general cycle of calcium storage, retrieval, deposition, and
disposal (see ref. [3] for a more detailed discussion; see Ryall’s
comprehensive and insightful review [51] on calcium granules,
now known to be found in organisms spanning a wide range of
phylogenetic complexities).
Against these developments, the NB phenomenology may be
seen to have come full circle, with the NB-like precipitations
representing no more than the simple outcome of a physiologically
relevant homeostatic cycle designed by nature to deal with excess
calcium and apatite. As such, and perhaps even ironically, given
the controversies generated by this topic, NB-like formations are
no less real and they do represent structures that are verifiable and
demonstrable. However, they certainly do not seem to represent
self-sustained lifeforms, primitive symbionts, or even transmissible
and infectious disease agents as originally proposed. Precisely
because such particles can be viewed now as comprising a part of
the normal cycle of calcium movement and disposal, it is
important to understand what exactly determines their assembly,
where they are distributed, and whether they have any
pathological role after all.
Here, we seek to dissect the role of serum proteins in the
assembly of NB-like formations using the in vitro reconstitution
methods established through our earlier studies [1–3]. In our
mind, it is critical to establish whether purified proteins like fetuin-
A or albumin are capable of replicating the entire NB
phenomenology in the absence of other organic moieties (lipids,
carbohydrates, and other proteins) that may also be present in the
same serum, body fluids, and tissues that had earlier been used to
‘‘grow’’ NB. If so, we want to know whether the simple
combination of minerals and proteins can give rise to both the
morphological diversity (pleomorphism) and the distinct chemical
signature deemed representative of NB-like formations as well as
serum calcium granulations [1–3].
Both albumin and fetuin-A have been linked to NB-like
formations [1–3,46]. We had established earlier that both
p r o t e i n sa r ea m o n gt h em o r ea b u n d a n tp r o t e i n sf o u n di nN B -
like particles cultured from FBS or human serum (HS) [1–3].
This observation not only reflects the high concentration of
albumin and fetuin-A in the serum, but also the fact that these
proteins bind avidly to the mineral phase of NB-like particles (see
refs. [1–3] and the references therein). In our hands, preliminary
experiments done with purified proteins indicate that albumin
and, even more noticeably, fetuin-A inhibit apatite formation in
the presence of excess calcium phosphate (e.g. at supersaturating
concentrations) but this inhibition is only transient and it is
followed by subsequent mineral precipitation [2]. However, it is
not clear whether fetuin-A and albumin will seed apatite when
added to a metastable solution exemplified by fresh culture
medium, as we seek to verify here. Given the wealth of
information accumulated on both albumin and fetuin-A insofar
as their roles in calcium and apatite binding and calcification are
concerned and their predominance among the proteins species
linked to NB-like formations, we want to further establish
whether the workings of these proteins alone can explain the
entire NB biology, and if so, whether there are differences seen in
t h ep r e s e n c eo fe i t h e rm e t a s t a ble or supersaturated calcium
phosphate solutions. Since protein-mineral reactions of this kind
may be involved in similar biomineralization processes in the
body, we believe that a better understanding of this type of
nanoparticle assembly may ultimately help address their
pathophysiological role in vivo.
Results and Discussion
Slow and Spontaneous Formation of NB-Like
Precipitations by Serum through a Dual Seeding-
Inhibitory Mechanism
All previous NB studies have used a source of proteins like
serum, followed by prolonged incubation in cell culture conditions
in order to demonstrate the formation of NB-like particles [4–9].
This kind of slow culturing process gives at best marginal particle
production over a period of several weeks, making the results
difficult to quantify or interpret. To address these concerns, we
have developed a simple culture methodology that allows for the
quantitative and reproducible reconstitution of nanoparticles as
well as the simultaneous comparison of a large number of samples
[2,3].
Figure 1 illustrates the phenomenon of NB-like particle
formation using this culture system and in response to the simple
inoculation of serum as a source of proteins and other organic
compounds. Here, the formation of precipitable complexes
resembling NB was monitored in 24-well plates containing
Dulbecco’s modified Eagle’s medium (DMEM) by means of
turbidity measurements as captured visually through photography
or by means of light spectroscopy reading at a wavelength of
650 nm (A650). Turbidity was seen to gradually increase with the
addition of either FBS or HS followed by incubation at 37uC for
several weeks (Fig. 1). Notably, two types of dose-dependence
could be discerned depending on the concentration of serum used.
Addition of low concentrations of either FBS or HS produced a
dose-dependent increase in turbidity while levels of serum
exceeding 0.3% for FBS and 5% for HS generally gave an
increasingly lower amount of precipitation or turbidity measure-
ment (Fig. 1A and B, respectively).
This dual dose-dependent response could be illustrated further
by fine-tuning the range of serum used. For FBS, we have found
that the use of a 100-fold difference in the amount of serum
inoculated, varying between 0.1 and 10%, generally encompassed
the entire range of dose-dependence observed (Fig. 1A). That is,
precipitation could be seen to increase steadily in proportion to the
amount of serum added, but only up to 0.3%, as illustrated both
by Figure 1A (well 3) shown here as well as by Figure 1A (well 2)
shown earlier [2]. Above 0.3% FBS, turbidity decreased
proportionally with the amount of serum inoculated, presumably
due to calcification-inhibitory influences exerted by the serum
(Fig. 1A, wells 4–6). While the peak precipitation seen with 0.3%
FBS varied with the source and batch of serum used, a bell-shaped
relationship was observed however with all of the FBS samples
tested.
For HS, on the other hand, we have noticed generally a
rightward shift of this same dose-dependent response when
compared to FBS that nonetheless retained its modal or dual
nature (Fig. 1B, compare also with Fig. 1A of ref. [2]). A 10-fold
HS concentration range was used in the experiment illustrated in
Figure 1B to illustrate this characteristic dual dose-dependence
and to better highlight the decrease of turbidity associated with
higher amounts of serum. Here, peak turbidity in DMEM was
seen at 1-to-3% serum after 1 month, and 3% at the end of 2
months (Fig. 1B, middle and bottom rows). This slight rightward
shift of the serum concentration associated with culture aging was
consistently more noticeable with HS than with FBS. As seen
earlier with FBS, while the different HS samples tested gave
variable precipitation amounts as well as peak turbidities, the dual
or bell-shaped dose-dependence was generally observed with all of
the serum samples tested to date.
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ed earlier as supporting a dual seeding-inhibitory concept for the
formation of NB in the presence of serum, in which calcification
inhibitors are seen both as interceptors of calcification as well as
seeds for the formation of NB-like calcium granules—a dual role
that is modulated by the amounts of calcium and phosphate
present in the medium [2,3]. That is, according to this model, the
same calcification inhibitors become calcification-seeding agents
when overcome by excess calcium and phosphate. Still in line with
this interpretation and in the context of our experiments, low
amounts of serum tended to seed NB-like precipitations (due to
calcium and phosphate exceeding the inhibitory activity of serum)
while higher serum amounts (exceeding 0.3% for FBS and 3% for
HS, as determined from the batches of serum tested here) became
increasingly inhibitory. This same inhibition appeared to last for
several weeks and was evident even after 2 months (Fig. 1A and B,
bottom rows). With this prolonged incubation, however, there
were signs of partial reversal of the inhibitory activity associated
with the serum, which was generally more evident in the case of
HS after 2 months (Fig. 1B, note the slight rightward shift for the
peak turbidity as compared to the peak seen at 1 month; several
other experiments, not shown, have given even more prominent
rightward shifts of the peak turbidity as a result of prolonged
incubation). That is, although higher amounts of HS still exerted
inhibitory influences on the observed precipitation, this same
inhibitory effect became much less apparent after an incubation of
2 months (Fig. 1B, compare the middle and bottom rows, wells 5
and 6). For FBS, on the other hand, the inhibitory patterns tended
to always last longer, and in this particular experiment, inhibition
could still be clearly seen after 2 months with FBS at 1% or higher
concentrations (Fig. 1A, bottom row, wells 4–6). This consistent
difference between FBS and HS supports the notion that the same
calcification-inhibitory influences exerted by HS are probably
more easily overcome with incubation than those associated with
FBS. This same difference can be further explained by the
significantly larger amounts of fetuin-A—one of the more potent
calcification inhibitors—found in FBS as compared with HS (10–
21 mg/ml in FBS vs. 0.7–0.8 mg/ml in HS; see more detailed
discussion in ref. [2] along with the many reference citations
therein).
Figure 1. Slow formation of NB-like particles by serum inoculated into DMEM. (A) Formation of NB-like particles by FBS. FBS was inoculated
into DMEM to the indicated % by volume. Visual inspection and A650 turbidity reading (insets) were performed within 1 hour following inoculation
(top panel, ‘‘Day 1’’) as well as after incubation at 37uC in cell culture conditions for ‘‘1 Month’’ (middle panel) or ‘‘2 Months’’ (bottom panel). Notice
the gradual increase in turbidity observed with time as well as the bell-shaped increase in turbidity as a function of the amount of serum inoculated,
with maximum turbidity reached at 0.3% FBS, while higher concentrations of FBS resulted in increasingly lower turbidities. (B) Formation of NB-like
particles by HS, performed as described in (A), except that higher serum concentrations varying from 1 to 10% were used. Notice the bell-shaped
increase in turbidity, with peak reached at 1-to-3% HS at ‘‘1 Month’’ and 3% at ‘‘2 Months.’’
doi:10.1371/journal.pone.0008058.g001
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reported elsewhere [2,3] that the formation of NB-like precipita-
tions is a slow process that takes at least several weeks to develop.
The results seen here with both FBS and HS resulting in marginal
and barely visible precipitations are in fact representative of
hundreds of seeding experiments that we have conducted over a
period of two years using a variety of serum batches and different
culture conditions. This slow deposition of mineral complexes may
explain the earlier lack of reproducible and quantifiable data
associated with NB that may have in turn given rise to many
erroneous interpretations in the past. Besides, we have noticed a
progressive dehydration of the medium used during the course of
the prolonged incubation needed for the demonstration of NB, a
process that may take upwards to 2 months, and this gradual
change in fluid conditions by itself can be shown to lead to
nanoparticle precipitation if not properly controlled (data not
shown). Nonetheless, at least in our hands, the gradual deposition
of mineral complexes in DMEM in response to the presence of
serum can indeed be verified as well as quantified.
Role of Proteins in the Formation of NB-Like Calcium
Particles: Effect of Proteases
Earlier results have shown that the inhibition of NB formation
produced by high amounts of serum can be abolished with the
protease trypsin [2]. Both FBS and HS that had been pre-treated
with trypsin readily seeded NB-like formations in a dose-
dependent fashion in the presence of exogenously added calcium
and phosphate (see Fig. 10 in ref. [2]). That is, upon addition of
1 mM each of calcium and phosphate to DMEM to reach
supersaturating levels, there was readily mineral precipitation; this
same precipitation could be inhibited by serum in a dose-
dependent manner, with inhibition correlating with the amount of
serum present [2]. However, serum that had been pre-treated with
0.5% trypsin no longer remained inhibitory [2]. In fact, not only
was it no longer inhibitory, this same trypsin-digested serum
actually promoted additional seeding of NB-like precipitations in a
dose-dependent manner [2]. Seeding seen with trypsinated serum
under these conditions was more immediate, taking a few days,
rather than several weeks, to complete [2]. These earlier findings
support the accepted notion that calcification in the serum—itself
considered a supersaturated solution with respect to calcium and
phosphate—as well as in living tissues in general is in fact
repressed by multiple inhibitory factors [52–58]. Our own
experiments have indicated that these same inhibitory influences
appeared to be at least partially proteinaceous in nature since they
were sensitive to tryptic digestion [2]. A subsequent study showed
further that treatment with either trypsin or chymotrypsin was
capable of precipitating mineral complexes directly from the
serum [3]; these same complexes in turn seeded NB-like
precipitations upon transfer to fresh medium (see Fig. 12 in ref.
[3]). These results demonstrate again the propensity for calcifica-
tion to occur within serum, and that this propensity is inhibited by
serum factors that are themselves sensitive, at least in part, to
protease digestion [3]. Our results demonstrate further that the
removal or de-repression of these same inhibitory influences
appears to be sufficient to bring about mineral precipitation in the
serum!
Given the importance of these preliminary results insofar as
implicating a role for proteins in the assembly of NB-like particles,
we repeated more carefully the trypsin digestion experiment in
order to explore in greater detail the nature of the seeding-
inhibition relationships associated with serum. This time, following
tryptic digestion of both FBS and HS, inoculation of trypsinated
serum into DMEM was done without any exogenous addition of
calcium or phosphate. Although mineral precipitation seen under
these conditions, e.g. in the absence of exogenously added
precipitating ions, takes much longer to develop, it allows for the
comparison between metastable and supersaturated medium
conditions, a distinction which we deem critical in order to assign
a definitive role for proteins in nanoparticle formation. Figure 2
shows typical results obtained with both FBS and HS that had
been pre-treated with 0.5% trypsin for 2 hours at 37uC, after
which the serum was inoculated into DMEM and further
incubated for the indicated times. Under these conditions, there
was a slow and gradual increase in turbidity associated with the
trypsinated serum. This increase in turbidity was significantly
higher than that seen with control serum in the same time period
(compare 1-month readings of Fig. 2 versus that of Fig. 1; for
brevity and ease of comparison, only A650 turbidity readings are
shown in Fig. 2). Turbidity increases were seen with both trypsin-
treated FBS and HS that were more prominent than those seen
with control FBS and HS (Fig. 2A and B; compare ‘‘None’’
column with ‘‘Trypsin’’ column). DMEM inoculated with either
trypsinated FBS or trypsinated HS failed to display a bell-shaped,
dose-dependent precipitation (Fig. 2A and B; note the bell-shaped
increase in turbidity evident with 0.1–0.3% of control, untreated
FBS and HS that is absent in trypsinated serum). Instead, with
both trypsinated FBS and HS, there was a serum dose-dependent
increase in turbidity that gradually increased with time.
Similar results were obtained with the protease chymotrypsin
tested exactly as trypsin (Fig. 2A and B). Accordingly, both FBS
and HS that had been treated with 0.5% chymotrypsin for 2 hours
at 37uC proceeded to seed NB-like precipitates slowly in DMEM
in a progressive, dose-dependent manner without the bell-shaped
curve seen with control, untreated serum (compare ‘‘Chymotryp-
sin’’ and ‘‘Trypsin’’ columns and these with untreated ‘‘None’’
column in Fig. 2A and B). In this respect, it should be noted that
earlier experiments done with both FBS and HS treated with
chymotrypsin also gave precipitations that were comparable to
those obtained with trypsin [3]. Together, these results indicate
that calcification-inhibitory factors in the serum were at least
partially removed or neutralized by the proteases trypsin and
chymotrypsin. Likewise, it can be concluded that these same
inhibitory influences are, at least partially, proteinaceous in nature.
For control, DMEM was inoculated with either FBS or HS pre-
treated with trypsin or chymotrypsin that had been heat-
inactivated for 1 hour at 95uC (labeled as ‘‘Boiled Trypsin’’ or
‘‘Boiled Chymotrypsin’’ in Fig. 2A and B). We reasoned that this
treatment provided a control not only for the presence of trypsin
but also for the presence of normal serum in DMEM. As expected,
inoculation of DMEM with either FBS or HS that had been pre-
treated with boiled trypsin or boiled chymotrypsin produced much
lower turbidity readings as compared with that obtained with
either trypsinated FBS or trypsinated HS. In fact, the low
turbidities obtained under these control conditions were compa-
rable to those seen using untreated serum as depicted earlier in
Figure 1 and in Figure 2A and B, seen under the ‘‘None’’ column.
That is, in spite of the low turbidities obtained under these control
conditions with boiled trypsin or boiled chymotrypsin, a dual dose-
dependent response could still be discerned, exactly as seen earlier
with untreated serum (Fig. 1 and Fig. 2A and B, ‘‘None’’ column).
As additional controls, both untreated and heat-treated trypsin or
chymotrypsin were added directly to DMEM to a final
concentration of 0.01–3% and the inoculated wells were incubated
for one month. No increase in turbidity was observed here as
compared with the control background DMEM (Fig. 2C). Given
the fact that serum samples pre-treated with 0.5% protease (trypsin
or chymotrypsin) were subsequently added to DMEM to 0.1–10%,
Protein-Mineral Nanoparticles
PLoS ONE | www.plosone.org 5 November 2009 | Volume 4 | Issue 11 | e8058Figure 2. Formation of NB-like particles from protease-treated serum. (A) NB-like particles cultured from protease-treated FBS. Stock
solutions of 5% (w/v) trypsin or chymotrypsin were diluted into FBS at the final concentration of 0.5% (v/v), followed by incubation at 37uC for
2 hours. After incubation, the two protease-treated FBS solutions were inoculated into DMEM (columns labeled as ‘‘Trypsin’’ or ‘‘Chymotrypsin’’) to
the concentrations indicated on the top heading, starting from 0% (e.g. untreated, well 1) up to 10% (well 6). FBS was also treated with trypsin or
chymotrypsin that had been inactivated by heat at 95uC for 1 hour (‘‘Boiled Trypsin’’ or ‘‘Boiled Chymotrypsin’’). For each treatment, A650 turbidity
readings were performed within 1 hour following inoculation (‘‘Day 1’’) and after incubation in cell culture conditions for ‘‘1 Week’’ or ‘‘1 Month’’,a s
indicated on the right. Untreated FBS (‘‘None’’ column) or FBS that was treated with either boiled trypsin or boiled chymotrypsin produced a low bell-
shaped curve of turbidity increase after 1 month of incubation. In contrast, inoculation of FBS that was treated with trypsin or chymotrypsin resulted
in a more prominent straight dose-dependent turbidity increase after 1 month of incubation. (B) NB-like particles cultured from protease-treated HS
were obtained as in (A). Notice the straight dose-dependent increase in turbidity, noticeable at ‘‘1 Month,’’ while both untreated HS and pre-boiled
HS produced a low bell-shaped turbidity response. (C) Control experiment, performed with both untreated and boiled proteases inoculated directly
into DMEM at the indicated % (w/v). No increase in turbidity was noticed for these control treatments following incubation.
doi:10.1371/journal.pone.0008058.g002
Protein-Mineral Nanoparticles
PLoS ONE | www.plosone.org 6 November 2009 | Volume 4 | Issue 11 | e8058the protease concentrations used for these last control experiments
would represent up to 60 times the amount of trypsin or
chymotrypsin used under the study conditions described here.
These results further indicate that the seeding effect seen in
DMEM is closely associated with body fluids like serum and that
this treatment cannot be replaced by the presence of proteases
alone. Together, these control experiments demonstrate that the
seeding effects seen with either trypsinated or chymotrypsinated
serum are not the result of artifacts associated solely with the
presence of proteases.
These findings clearly complement and support the earlier
results obtained with trypsinated serum inoculated into DMEM
that had been supplemented with additional calcium and
phosphate [2]. There, adding exogenous calcium and phosphate
to DMEM to supersaturating levels resulted in immediate
precipitation, which in turn could be effectively inhibited by
serum. However, serum that had been trypsinated was shown to
be no longer inhibitory but, instead, seeded more NB than could
be accounted by the addition of calcium and phosphate alone,
with the resultant seeding correlating directly with the amount of
trypsinated serum added [2]. Likewise, treatment of serum with
either trypsin or chymotrypsin readily resulted in mineral
precipitation that in turn could be used to further seed NB-like
formations in fresh medium [3]. These results were interpreted as
a release of inherent calcification-inhibitory pathways that
appeared to be protease-sensitive. Here, in contrast, mineral
precipitation was allowed to progress on its own in DMEM
without the addition of exogenous precipitating ions. Under these
conditions, it can still be seen that the same protease-treated serum
also produced more precipitation than control serum; moreover,
seeding no longer showed a dual response, indicating the
dampening or release of serum-mediated inhibition produced by
means of protease treatment. These results suggest that protease-
sensitive proteins in the serum may account at least in part for
both NB-like seeding and inhibition capabilities associated with
normal serum, a fact that can be reproduced with solutions
containing both metastable and supersaturating calcium concen-
trations. About the only difference seen here with the two types of
calcium environment is that the calcification reaction is enhanced
many fold in the presence of excess calcium under supersaturating
conditions as compared with metastable calcium environments.
On the other hand, the results shown here do not preclude the
participation of other protease-insensitive or non-proteinaceous
moieties (perhaps small peptides, glycoproteins, lipids, and
carbohydrates) in this type of calcification reaction.
Role of Proteins in the Formation of NB-Like Calcium
Particles: Effect of Heat Treatment and Distinction
between Metastable and Supersaturated Calcium
Solutions
Other treatments were sought to verify the role of proteinaceous
serum factors in creating (or inhibiting) NB-like particles in
metastable solutions like DMEM. Heat treatment of proteins is
commonly used as a way of denaturing proteins or inducing
conformational changes. Figure 3 shows the results obtained with
boiling FBS or HS followed by inoculation into DMEM. Heat
Figure 3. Formation of NB-like particles from boiled serum in metastable versus supersaturated medium. (A) Metastable medium: FBS
and 25% HS were boiled at 95uC for the time indicated on the left panel (0, 10, 30, and 120 min). ‘‘0 min’’ refers to control, untreated serum. The
boiled sera were then inoculated into DMEM to the concentrations shown on the top heading. (B) Supersaturated medium: both FBS and HS were
treated as described in (A), except that 1 mM each of CaCl2 and NaH2PO4 (labeled as ‘‘Calcium+Phosphate Added’’) was added following the
inoculation of the boiled serum into DMEM. Note the marked differences in turbidity changes between the various panels shown in (A) versus (B). See
the text for explanation and interpretation.
doi:10.1371/journal.pone.0008058.g003
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various periods of time (10, 30, and 120 min). While the boiled
serum became more opalescent and occasionally showed white
precipitations, the entire serum solution was used for inoculation
without further processing. As can be seen, there is an increase in
seeding by at least several fold as compared with non-boiled
control serum (Fig. 3A). This increase in turbidity seen with serum
that had been boiled for 10 or 30 minutes occurred gradually and
was not the result of an immediate precipitation due to heat
treatment of serum alone (note the low turbidity seen on ‘‘Day 1’’).
However, with longer boiling times (120 min), some immediate
precipitations were seen on ‘‘Day 1,’’ which in this particular
experiment were more noticeable with FBS as compared to the
HS sample used (Fig. 2A). With even longer boiling times
(overnight), mineral precipitation was obvious in the serum even
prior to seeding (data not shown). Nonetheless, from Figure 3A, it
can be seen that there was a slow and gradual increase in turbidity
associated with the higher amounts of boiled serum used over the
course of several weeks of incubation (compare ‘‘1 Month’’ and
‘‘Day 1’’ readings). However, as evidenced with protease-treated
serum, the same bell-shaped, dose-dependent precipitation seen
earlier with control, untreated serum was no longer apparent with
serum that had been boiled. That is, it appears that the inhibition
seen with higher amounts of serum (exceeding 1–3% in the case of
FBS and HS) was somehow released through the boiling
treatment.
To further verify whether there are differences seen between
metastable versus supersaturated calcium and phosphate solutions
with respect to the effects of boiled serum, we repeated the same
seeding experiment with DMEM shown in Figure 3A, supple-
mented however with 1 mM calcium and phosphate. Mineral
precipitation, along with an increase in turbidity, was immediate
under these conditions (Fig. 3B, ‘‘Day 1’’). Untreated, control
serum (both FBS and HS) at higher concentrations (1% for FBS
and 3% for HS) was capable of exerting immediate, partial
inhibition of this same mineral precipitation (Fig. 3B, see the row
‘‘0 min Boiling Time’’ within the ‘‘Day 1’’ panel), an inhibition
that could be sustained for several days (Fig. 3B, compare with
‘‘Day 4’’ panel). Thus, this precipitation showed a prominent bell-
shaped, dual relationship as a function of the serum amount
added, in line with the data published earlier [2].
In the presence of boiled serum, however, the same DMEM
challenged with exogenous calcium and phosphate (1 mM)
displayed a pattern of response that differed markedly from that
seen with DMEM alone (e.g. without the presence of additional,
exogenously added calcium and phosphate). As can be seen in
Figure 3B, the addition of 1 mM calcium and phosphate to
DMEM produced immediate precipitation associated with
turbidity increase (wells 1, ‘‘Day 1’’). Turbidity did not increase
significantly thereafter (compare with ‘‘Day 4’’). As noted before,
the presence of control FBS or HS in DMEM resulted in partial
inhibition of this same turbidity produced by 1 mM calcium and
phosphate (seen from control rows identified by a boiling time of
‘‘0’’ min, Fig. 3B). Moreover, both FBS and HS that had been
boiled for 10 and 30 minutes produced the same partial inhibition
of turbidity immediately after seeding (‘‘Day 1’’). In the case of
FBS, this same partial inhibition could still be seen on Day 4
(Fig. 3B, ‘‘Boiled FBS’’ column). For HS, on the other hand, this
inhibition was released after 3 days, being replaced by a straight,
dose-dependent change in turbidity that increased with the
amount of HS present (Fig. 3B, ‘‘Boiled HS, Day 4’’). Upon
using either FBS or HS that had been boiled for 120 minutes,
however, this same inhibition was immediately released and a
dose-dependent increase in turbidity could be seen both on ‘‘Day
1’’ and ‘‘Day 4’’ (Fig. 3B). In fact, the addition of boiled serum
produced an additive precipitation effect on top of the precipita-
tion seen with the exogenous addition of 1 mM of calcium and
phosphate alone that was in itself dose-dependent (Fig. 3B, more
evident with all the boiled HS samples tested, but also seen with
FBS that had been boiled for 120 min). Upon longer incubation
(up to 1 month), a progressive increase of turbidity was observed
with all serum treatments, resulting in the reversal or overcoming
of the seeding-inhibition seen at the earlier time points (data not
shown).
With respect to supersaturated calcium and phosphate solu-
tions, these results would seem to indicate that the calcification-
inhibitory influences seen associated with serum are only partially
sensitive to heat exposure and that extensive boiling and
denaturation are required to effect their inactivation. In this same
context, our results indicate that, for FBS, the same calcification-
inhibitory factors show a higher resistance to heat inactivation as
compared with HS. Our findings also reveal that the ‘‘seeding’’
and ‘‘inhibitory’’ tendencies associated with serum can be clearly
distinguished by the experimental set-up used here. Thus, in the
case of metastable medium (DMEM), the ‘‘seeding’’ aspects of the
boiled serum can be more readily revealed. On the other hand,
with supersaturated calcium and phosphate solutions displaying
high natural propensity to calcify, it is the ‘‘inhibitory’’ aspects of
the serum that are more readily evident and that in turn are either
partially or completely removed through boiling.
These results further indicate that the use of metastable and
supersaturated calcium and phosphate solutions may allow for the
elucidation of certain mechanistic aspects of nanoparticle
physiology that would not have been possible by making use of
only metastable conditions. Earlier, we used exogenous precipi-
tating ions to enhance the biomineralization process many fold—a
strategy that was adopted to amplify precipitation and to obtain
more quantifiable and reproducible data [2,3]. Here, we have
noticed that in addition to enhancing the calcification process, the
addition of small amounts of calcium and phosphate could be used
as a tool to study the role of serum and proteins in the context of
the dual inhibition-seeding model proposed here for nanoparticle
assembly. It should be further noted that DMEM contains
1.8 mM calcium and 0.9 mM phosphate. The addition of up to
1 mM of calcium and phosphate, as we have done in the
experiment depicted in Figure 3B, gives final concentrations of
2.8 mM calcium and 1.9 mM phosphate, resulting in an ion
product of 5.32610
26 M
2, still below the cut-off value of
6610
26 M
2, above which any solution at physiological pH, ionic
strength, and body temperature—serum in body conditions for
example—has been found to precipitate spontaneously [56]. Yet,
the ion product obtained with such low amounts of calcium and
phosphate is sufficient to reveal important differences between this
ionic environment and metastable solutions like DMEM. In fact,
we have noticed that as little as 0.7 mM calcium and phosphate,
and at times, as little as 0.3 mM calcium phosphate, inoculated
into DMEM will result in gradual mineral precipitation, giving
results that are similar to those seen here with 1 mM calcium and
phosphate except for a slower kinetics (data not shown). We have
noticed further that the level of precipitating ions required to
induce mineral deposition was clearly dependent on the age of the
medium, its pH, and other environmental factors, such as the
frequency with which the plates were examined and how long they
were left out at room temperature (unpublished observations).
These results indicate that one can easily simulate supersaturated
calcium and phosphate conditions with minimal additions of
exogenous calcium and phosphate, enabling one to minimize the
ionic perturbation of the medium being studied.
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Metastable Versus Supersaturated Calcium and
Phosphate Solutions
With respect to nanoparticle formation and calcification, our
experiments clearly indicate that both inhibitory and seeding
influences are seen to be associated with serum, and, furthermore,
that at least some of these inhibitory influences can be removed
through protease and heat treatment of the serum tested. These
results would also suggest a critical role for proteins in this same
process of mineral precipitation, perhaps by their initiating
nanoparticle formation, itself probably representing an early step
of the biomineralization process. This possibility prompted us to
investigate more carefully the role of purified serum proteins in
mediating nanoparticle formation.
For our protein studies, we chose to use albumin and fetuin-A
not only because they had been shown to be involved in calcium
nanoparticle formation [1–3,46] but also because of extensive
studies pointing to an active role for both proteins in regulating
calcium and apatite homeostasis in the blood [56,57,59–68] as
well as in mediating calcification reactions elsewhere in the body
[69–77]. Fetuin-A, for instance, is a potent calcification inhibitor,
known to bind strongly to both calcium and nascent apatite
crystals. By itself, fetuin-A accounts for about half to one-third of
the total serum inhibitory capacity directed against spontaneous
apatite precipitation associated with supersaturated solutions of
calcium and phosphate [57,66]. As for albumin, according to
Garnett and Dieppe, it ‘‘not only accounts for half of the protein
concentration in serum, but also contributes half of the inhibitory
activity [directed against apatite crystal growth and associated
with] the high-molecular-mass fraction’’ [62]. Intriguingly,
albumin and fetuin-A represent two of the most abundant non-
collagenous proteins found in the bones. For instance, albumin is
found at 0.7 mg/g of bone in bovines [78] whereas fetuin-A is
usually found at 0.9 to 1 mg/g of bone in rats [79], bovines [78],
and humans [80]. Both proteins are also found associated with
protein-mineral complexes that form in the serum under
conditions in which ectopic calcification is triggered. Such
protein-mineral complexes have been shown for instance to form
in the serum of animals treated with vitamin D, warfarin,
etidronate, or adenine, all known to modulate or perturb calcium
homeostasis and to induce calcification [69–72,76]. Similarly, both
albumin and fetuin-A are present in mineral complexes isolated
from humans undergoing severe extra-skeletal calcification as seen
in cases of calcifying peritonitis [74]. The concept that these
proteins act as systemic calcification inhibitors is illustrated by the
observation that fetuin-A-deficient mice spontaneously develop
ectopic calcification when fed with a diet rich in mineral and
vitamin D [67,68]. On the other hand, evidence suggests that
albumin may promote mineral formation in some experimental
conditions, an observation that would confer to this protein a dual
inhibition-nucleation role on nanoparticle formation. For instance,
albumin at low concentrations (under 10 mg/ml) promote the
deposition of calcium phosphate on collagen while higher
concentrations (above 10 mg/ml) inhibit collagen mineralization
[81,82]. In addition, albumin has also been shown to promote the
precipitation of calcium phosphate in metastable solutions when
adsorbed onto HAP crystals [83,84]. It seems important therefore
to verify whether albumin and fetuin-A may lead directly to
calcium nanoparticle formation under the culture conditions used
to study NB and nanobacteria-like particles (NLP) in the past.
Through our earlier studies, we have shown that both bovine
and human forms of albumin and fetuin-A are integral
components of calcium nanoparticles formed from serum [1–3].
In fact, antibodies thought to be directed earlier against human
NB [5,8,24,26–29,35,37,39,85–91] have been shown to cross-react
across species against fetuin-A and albumin from both FBS and
HS [1–3]. From our own antibody analysis, we have inferred
earlier that both bovine and human antigens may be present in all
the earlier NB studies done to establish the presence of
nanobacterial antigens in human tissues; in those earlier studies,
NB were supposedly ‘‘grown’’ in medium supplemented with
untreated or gamma-irradiated FBS (described in more detail in
refs. [2,3], and the many references cited therein). Thus, for the
purpose of demonstrating a role for proteins in the assembly of NB
and NLP, we used both the bovine and human forms of albumin
and fetuin-A in the current study. For brevity, however, only
results pertaining to human serum albumin (HSA) and bovine
serum fetuin-A (BSF) are shown in most experiments. These forms
are not only more readily available in commercial quantities but
they are used here to allow us to confirm that these proteins will
bind strongly to nascent calcifying nanoparticles regardless of their
species of origin. It should be noted that the use of the other two
forms of these proteins (bovine serum albumin and human serum
fetuin-A) have given comparable results.
Figure 4 (column marked by ‘‘None’’) shows typical results
obtained with inoculating either BSF, HSA, or both into DMEM
and observing for turbidity changes over various periods of time
(data shown up to 1 month). Surprisingly, no precipitation was
seen with any of the three types of inoculation, with proteins added
between 0.04 and 4 mg/ml and observed for extended periods of
times of up to 2 months (data not shown). These results are
representative of a total number of 15 separate experiments done
over a course of two years by several independent researchers.
Turbidity and precipitation that had been seen in some initial
experiments were later traced to bacterial contamination associ-
ated with the protein solutions; after filtration through 0.2-mm
membranes, proteins no longer produced precipitation in spite of
prolonged incubation. To ensure that the results were not due to
proteins being filtered out, the same solutions were inoculated
without filtration but in the presence of 0.02–0.2% sodium azide
added to the medium. No precipitation was seen under these
conditions.
In other experiments (Fig. 5), albumin was increased 10-fold up
to 40 mg/ml so as to mirror its normal concentration in the
serum, at 35–45 mg/ml in HS [92] and 23 mg/ml in FBS [93].
Likewise, BSF was tested up to 20 mg/ml in some experiments
(not shown). Precipitation was not seen within this broad spectrum
of protein concentrations. Precipitation was also not evident when
proteins were tested against other cell culture media (Roswell Park
Memorial Institute 1640 or RPMI-1640, F12 medium, medium
199, Glascow minimum essential medium, and Leibovitz L-15
medium, all obtained from Gibco; data not shown).
Since neither albumin nor fetuin-A could seed calcium
nanoparticles in metastable solutions, inoculation was carried out
in DMEM in the presence of small amounts of calcium and
phosphate. Figure 4A shows results for three concentrations of
calcium and phosphated added: 0.1 mM, 0.3 mM, and 0.5 mM.
In the presence of 0.1 mM calcium and phosphate, a progressive,
slow, dose-dependent turbidity increase was seen with subsequent
addition of either BSF or HSA. In contrast, 0.1 mM calcium and
phosphate alone, in the absence of proteins, did not produce any
turbidity changes in the same period of observation, indicating
that the turbidity seen with either HSA or BSF was not due to
spontaneous or homogeneous mineral deposition associated with
the presence of precipitating ions. The inoculation of both BSF
and HSA in the same wells resulted in a bell-shaped turbidity
increase, with peak turbidity induced by 1.2 mg/ml each of BSF
and HSA added, and decreasing thereafter with larger doses of
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PLoS ONE | www.plosone.org 9 November 2009 | Volume 4 | Issue 11 | e8058Figure 4. Seeding of NB-like particles by fetuin-A, albumin, and serum in metastable versus supersaturated medium. (A) Fetuin-A and
albumin in both metastable and supersaturated media: bovine serum fetuin-A (BSF) and human serum albumin (HSA) were diluted into DMEM,
separately or together, to the final concentrations indicated on the top. Where indicated, CaCl2 and NaH2PO4 were added to the final concentrations
shown at the bottom (labeled as ‘‘Calcium+Phosphate Added’’), followed by incubation in cell culture conditions for ‘‘1 Week’’ or ‘‘1 Month’’, as
indicated on the right of each panel. ‘‘None’’ refers to the absence of any exogenously added calcium and phosphate, that is, to metastable medium
DMEM. Seeding of the proteins alone without additional ion input did not produce any turbidity change even following incubation for 1 month
(‘‘None’’ column). Low amounts of precipitation were noticed when precipitating ions were added (supersaturated solutions) that increased gradually
over time through either bell-shaped (BSF, BSF and HSA) or straight, dose-dependent (HSA) relationships. (B) Serum in supersaturated medium: FBS
(top panel) or HS (lower panel) were added to the final concentrations indicated on the top, followed by addition of precipitating reagents to the
concentrations shown at the bottom. Addition of precipitating reagents at either 0.1, 0.3, or 0.5 mM into DMEM containing FBS or HS produced
turbidities which increased steadily as seen after ‘‘1 Week’’ either through bell-shaped (0.1 mM calcium and phosphate) or straight, dose-dependent
(0.3 and 0.5 mM calcium and phosphate) relationships. After further incubation, all treatments showed straight dose-dependent turbidities that
continued to increase in a slow and gradual manner (‘‘1 Month’’).
doi:10.1371/journal.pone.0008058.g004
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proteins together produced an additive inhibitory effect that
reflected the summation of the individual effects associated with
either BSF or HSA. In all three instances, however, the increase of
turbidity was slow, taking at least two weeks to become noticeable.
In the presence of both 0.3 mM and 0.5 mM calcium and
phosphate, precipitation could be discerned earlier and, by one
week, noticeable increases in turbidity were measured (Fig. 4,
‘‘0.3 mM’’ and ‘‘0.5 mM’’ columns). On the other hand, adding
calcium and phosphate alone at these levels produced no increase
in turbidity during the same periods of time (up to 1 month, wells 1
in each column, Fig. 4A). In the presence of added calcium and
phosphate (0.3 mM and more noticeably with 0.5 mM), a bell-
shaped dose-dependence was clearly seen with BSF, but not with
HSA. HSA alone produced a simple, dose-dependent increase in
turbidity without any noticeable inhibition seen with higher
protein concentrations. In the presence of both BSF and HSA,
however, the same bell-shaped dose-dependence could also be
discerned, seemingly translating into an additive inhibitory effect
produced by the individual BSF and HSA moieties. These results
indicate that, in addition to both BSF and HSA displaying seeding
capability in the presence of small amounts of calcium and
phosphate added, only BSF showed clear inhibitory tendencies in
the protein concentrations tested here.
To correlate these findings with those seen with unfractionated
whole serum, we repeated the same experiments by inoculating
FBS or HS into DMEM containing various amounts of calcium
and phosphate. Figure 4B demonstrates again the slow, bell-
shaped seeding that is seen with either FBS or HS inoculated into
DMEM alone in the absence of any externally added calcium and
phosphate (‘‘None’’ column). In the presence of 0.1 mM calcium
and phosphate, however, a much more prominent turbidity
increase could be seen with either FBS or HS that was not
apparent with calcium and phosphate alone. Again, turbidity
appeared to peak at 1% FBS and 0.3% HS after 1 week, and at
10% FBS and 3% HS after 1 month (Fig. 4B, ‘‘0.1 mM’’ column).
In the presence of higher amounts of calcium and phosphate
(0.3 mM and 0.5 mM), the turbidity increase was enhanced, and
by one week, precipitation had nearly reached maximal levels
(Fig. 4B). It should be noted that, by one week, peak turbidity was
seen at 3% FBS or HS, while 10% FBS or HS gave lower
turbidities, indicative of a bell-shaped dose-dependence. However,
with longer incubations, up to 1 month, some of this same
inhibition seen at higher doses of serum appeared to have been
subdued or overcome (Fig. 4B). Together, these results indicate a
similar type of seeding-inhibition relationship seen with the whole
serum that can be mimicked at least in part by the two purified
serum proteins albumin and fetuin-A.
That albumin and fetuin-A should differ in their effects on
mineral precipitation (Fig. 4A) may be explained by their
differential affinities for calcium and apatite. In fact, compared
to albumin, fetuin-A is known to bind much more strongly to
calcium. For instance, fetuin-A was described to have 6 calcium-
binding sites, with one of them being associated with a binding
constant of 0.95610
24 M in the case of BSF and 1.42610
24 M
for HSF [65]. On the other hand, bovine serum albumin (BSA)
Figure 5. Effect of high concentrations of fetuin-A and albumin on the formation of NB-like particles in metastable versus
supersaturated medium. Stock solutions of BSF and/or HSA were diluted into DMEM to the concentrations indicated on the top, so as to mimick
the concentration range of these proteins seen in HS. When indicated, the precipitating reagents CaCl2 and NaH2PO4 were added to the
concentrations shown at the bottom (labeled as ‘‘Calcium+Phosphate Added’’). A650 turbidity readings were performed following inoculation (‘‘Day
1’’) and after incubation in cell culture conditions for ‘‘1 Month’’, as indicated on the right. Seeding of the proteins alone without additional
precipitating reagents did not produce any turbidity increase even following incubation for 1 month (‘‘None’’ column). Notice the bell-shaped
turbidity increases seen with 0.3 mM and 0.5 mM calcium and phosphate columns, observed at ‘‘1 Month,’’ but not ‘‘Day 1.’’
doi:10.1371/journal.pone.0008058.g005
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higher calcium-binding constant of 7610
23 M [65]. Fetuin-A is
also known to have unique apatite-binding sites ([94]; reviewed
also by Jahnen-Dechent et al. in ref. [75]). In earlier studies on
nanoparticle formation, it had also been shown that, compared to
albumin, fetuin-A is a much more potent inhibitor of calcification
[2]. This inhibition, however, appears to be transient, being
overcome gradually through incubation, a phenomenon that
seems to correlate with what has been seen with whole serum, as
shown here and elsewhere [2].
In addition to the inherent differences in calcium and apatite-
binding affinities between fetuin-A and albumin, it is also known
that, compared to fetuin-A, albumin is found in much higher
amounts in HS. At 35–45 mg/ml in HS [92], albumin is 50–56x
more abundant than fetuin-A (0.7–0.8 mg/ml [95]; see also ref.
[2]). In FBS, on the other hand and as noted earlier, albumin is
reportedly found at 23 mg/ml [93] while fetuin-A has been
measured at 10–21 mg/ml [96]. The differences in the concen-
trations of these two proteins in HS versus FBS as well as the
differences in their respective affinities for calcium and apatite
indicate that fetuin-A and albumin may exert markedly different
seeding or inhibitory influences insofar as nanoparticle formation
is concerned.
To address these inherent differences between fetuin-A and
albumin, we repeated the same seeding experiments shown in
Figure 4A, however this time using higher concentrations of
albumin (up to 40 mg/ml). We reasoned that increasing the
amounts of albumin used would mirror more closely the normal
concentrations of albumin found in both HS and FBS. Figure 5
shows one such series of experiments done in the presence of
0.3 mM and 0.5 mM calcium and phosphate. Either fetuin-A or
albumin at the concentrations tested (BSF up to 1 mg/ml; HSA up
to 40 mg/ml) produced similar bell-shaped, dose-dependent
seedings indicative of seeding-inhibition seen with the higher
doses of albumin used. In this particular experiment, BSF and
HSA concentrations above 0.1 mg/ml and 5 mg/ml, respectively,
gave progressively lower turbidities. When added together, fetuin-
A and albumin produced additive inhibitory effects (Fig. 5). Again,
in the absence of externally added calcium and phosphate, neither
fetuin-A (BSF, 0.1–1 mg/ml) nor albumin (HSA, 5–40 mg/ml)
produced any noticeable precipitation after 1 month. Adding the
two proteins together (BSF up to 1 mg/ml, HSA up to 40 mg/ml),
without any externally added ions, also failed to produce any
precipitation (Fig. 5).
The seeding-inhibitory relationships displayed by both fetuin-A
and albumin varied with the protein lots as well as the
concentrations tested, which gave a significant margin of error.
Nonetheless, the basic seeding and inhibitory influences delineated
by these proteins remained unchanged. For instance, Figure 6
illustrates another experiment in which BSF was adjusted between
0.7–70 mg/ml and HSA between 0.04–4 mg/ml. In the presence
of 0.3 mM, 0.5 mM, and 0.7 mM calcium and phosphate, these
protein ranges gave prominent bell-shaped, dose-dependent
increases in turbidity. Turbidity increases could be seen within
4 days of incubation and increased only slightly up to 1 month
(Fig. 6). With BSF, at 4 days, turbidity increased with BSF
concentrations up to 2.1 mg/ml, decreasing thereafter. Likewise,
for HSA, turbidity peaked between 120 to 400 mg/ml of protein
concentration and similarly decreased with additional protein
input. The protein concentrations seen to produce peak turbidities
in this experiment are surely different from those seen elsewhere
using different lots of proteins (compare Fig. 6 with 4A).
Remarkably, in the experiments depicted in Figure 6, as little as
0.7 mg/ml of BSF was sufficient to induce increased mineral
precipitation in the presence of submillimolar amounts of calcium
and phosphate (0.3 mM, 0.5 mM, and 0.7 mM; see wells 2 in all 3
columns of Fig. 6).
The lack of any noticeable inhibitory effect on mineral
precipitation seen with low doses of fetuin-A (0.7–2.1 mg/ml of
BSF) further confirms the notion proposed here that, at low
concentrations of fetuin-A, this same calcification inhibitor binds
avidly to nucleating apatite complexes, but it is eventually
overwhelmed by excess calcium and phosphate, at which point
it becomes a ‘‘nidus’’ for further calcification. In fact, as seen in
Figure 6, the peak turbidity can be seen to shift progressively
toward the right following an increase in the calcium and
phosphate concentrations added (compare the various columns).
Thus, in the presence of 0.3 mM calcium and phosphate, as little
as 2.1 mg/ml of BSF produced peak turbidity, whereas with
0.7 mM calcium and phosphate, the peak turbidity was seen with
BSF at 21 mg/ml, a result seemingly confirming the workings of an
optimal stoichiometric balance between fetuin-A and its mineral-
seeding capability as a function of the total amount of precipitating
ions present in any given medium. Beyond these peak concentra-
tion levels of turbidity, inhibitory influences could be clearly
discerned in both these experiments (see, for instance, wells 4–6 in
the 0.3 mM calcium and phosphate column and well 6 in the
0.7 mM calcium and phosphate column).
Assuming further a molecular weight of 48 kDa for BSF, it can
be calculated that at 0.7 mM of calcium and phosphate ions, the
optimal turbidity produced by 21 mg/ml, or 0.44 mM, corresponds
to the binding of 58 apatite units by each BSF molecule. The
number of apatite crystals bound to each protein molecule was
estimated by dividing the number of phosphate ions present in the
well producing maximal precipitation by the number of protein
molecules present in the same well as described in the Materials and
Methods. Phosphate ions were considered to be the limiting factor
in the formation of apatite crystals since they were present in lower
amounts than calcium ions. We assumed further that every
phosphate ion would be part of a crystal unit of apatite under these
conditions and that each crystal unit would contain an average of
63 phosphate ions based on earlier estimations [94]. On the other
hand, by using an average number of 105 calcium ions for each
apatite unit [94] as the basis of our calculation, an estimate of 54
apatite units bound to each BSF molecule was obtained. Either
way, the calculations given here correspond at best to only rough
approximations since we did not attempt to define more precisely
the dose-dependence relationship for BSF insofar as mineral
precipitation is concerned. In general, however, our calculated
number supports the earlier estimates made by Heiss et al. [94],
who established that each molecule of BSF could bind to 10
apatite units for early soluble calciprotein particles (CPPs) or to
around 22 apatite units for their so-called ‘‘precipitating late’’
CPPs.
Similar stoichiometric relationships could be defined for
albumin, with peak turbidities seen around 0.4 mg/ml (5.88 mM
assuming a molecular weight of 68 kDa for albumin) in the
presence of 0.7 mM of calcium and phosphate, which would
correspond to a stoichiometric binding ratio of 4 apatite units per
molecule of albumin. Compared to fetuin-A then, the binding
affinity of albumin for apatite is some 14-fold lower. Compared
however to the protein concentrations that produce maximal
turbidity/precipitation here in the presence of 0.7 mM calcium
and phosphate, both proteins are known to be present in the
serum at levels that are at least 100-fold higher. Given their
predominance in the serum, both proteins are expected to exert a
strong inhibitory influence on mineral growth and precipitation
even under conditions when the serum is loaded with excess
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PLoS ONE | www.plosone.org 12 November 2009 | Volume 4 | Issue 11 | e8058Figure 6. Seeding of NB-like particles by fetuin-A and albumin at low concentrations in supersaturated ionic solutions. Stock
solutions of BSF and/or HSA were diluted into DMEM to the relatively low concentrations shown on the top. The precipitating reagents CaCl2 and
NaH2PO4 were then added at either 0.3, 0.5, or 0.7 mM, as indicated at the bottom (labeled as ‘‘Calcium+Phosphate Added’’). Turbidity was
monitored by A650 turbidity reading following inoculation (‘‘Day 1’’) and after incubation in cell culture conditions for the time indicated on the right
side of each panel. Bell-shaped curves of precipitation were noticed at ‘‘Day 4’’ for the three different combinations of proteins as well as the three
different concentrations of added precipitating reagents. Precipitation in these conditions increased in a time-dependent manner with further
incubation. When 0.3 mM of precipitating reagents was used, bell-shaped increases in turbidity were seen for the three protein combinations after
1 month of incubation. With calcium and phosphate added to 0.5 and 0.7 mM, the initial bell-shaped increase in turbidity observed at ‘‘Day 4’’ was
seen to shift to the right at ‘‘1 Month’’ reading.
doi:10.1371/journal.pone.0008058.g006
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already revealed the need for an unusually high amount of calcium
or phosphate added to the serum in order for mineral precipitation
to ensue.
The turbidity profiles seen in Figure 6 could be sustained largely
unchanged for several weeks of incubation except for small shifts in
dose-dependence seen with longer incubation times (Fig. 6, see ‘‘1
Month’’ reading). It should also be noted that that these same
experiments showed a stronger inhibitory effect associated with
albumin as compared with earlier results (Fig. 4A). Nonetheless,
both seeding and inhibitory influences are readily apparent for
both proteins from the turbidity data shown here. As before, the
presence of both fetuin-A and albumin in the same culture wells
appeared to produce additive inhibitory effects.
Heat Treatment of Fetuin-A and Albumin as a Means to
Induce Conformational Changes and to Trigger the
Seeding of Minerals: Differences Seen between
Metastable and Supersaturated Calcium and Phosphate
Solutions
The seeding effects seen with both fetuin-A and albumin,
manifested only in the presence of exogenously added calcium and
phosphate, but not with metastable medium, were initially
puzzling. The results would seem to indicate that the calcium
and phosphate ions found in the DMEM may be stably complexed
with other ionic and organic moieties, such that the added
presence of fetuin-A and/or albumin is probably not sufficient to
perturb this equilibrium. Viewed from a different perspective, it
can also be inferred that the calcium (1.8 mM) and phosphate
(0.9 mM) concentrations present in DMEM are not sufficient to
saturate either fetuin-A or albumin, however little amount of
either protein is added, such that the calcification-inhibitory
potential associated with either one of these proteins might be
overcome. Apparently, in the presence of additional calcium and
phosphate ions added to the medium, there is now the binding of
these excess free precipitating ions by these two proteins that, upon
reaching saturation, may become the nuclei or nidi for the growth
of apatite crystals.
To confirm this notion and to further correlate the results
obtained for fetuin-A and albumin with those obtained earlier for
whole serum with respect to nanoparticle formation, we next
subjected both proteins to heat treatment for different lengths of
time, following the same protocol used earlier with whole serum.
We reasoned first that there is a fundamental difference seen with
metastable and supersaturated calcium and phosphate solutions
insofar as the mineral-seeding potential of fetuin-A and albumin is
concerned that may be related to the conformational states of
these protein molecules. We reasoned further that harsh
treatments like boiling may induce the conformational changes
required to unfold fetuin-A or albumin that in turn may allow
either one or both to induce mineralization in a metastable
medium like DMEM.
In Figure 7, both BSF and BSA were boiled for either 10, 30, or
120 min, followed by inoculation into DMEM in the absence
(Fig. 7A) or presence (Fig. 7B) of exogenously added calcium and
phosphate. Up to 2 mg/ml of BSF and 4 mg/ml of BSA were
used for the experiments described here. As can be seen from
Figure 7A, BSF that had been boiled for either 10, 30, or 120 min
did not give any precipitation when inoculated into DMEM alone,
in the absence of any added calcium or phosphate. In the same
series of experiments, it could also be noticed that the addition of
control, untreated BSF to DMEM also did not produce any
precipitation (Fig. 7A, row labeled as ‘‘0 min Boiling Time’’), in
line with the earlier experiments that failed to detect any
precipitation under these conditions (compare with the data
shown in Figs. 4A and 5). On the other hand, pre-boiled BSA
produced precipitation that could be readily detected following
1 month of incubation (Fig. 7A, ‘‘Boiled BSA’’ column).
Precipitation appeared to be a function of the boiling time, with
a 120-minute boiling treatment resulting in an immediate dose-
dependent precipitation detectable on the first day following
inoculation, presumably due to drastic protein denaturation. In
fact, following this prolonged heat treatment (120 min), the BSA
suspension became turbid and appeared to contain fine aggre-
gates. After the first day, the turbidity of the inoculated medium
did not seem to increase significantly when measured again after 1
month (Fig. 7A). On the other hand, boiling BSA for 10 or 30
minutes did not appear to create any turbidity increase, as
evidenced by the turbidity measurements collected on the first day
following inoculation (Fig. 7A). Turbidity however increased
gradually over a period of 1 month, following a bell-shaped,
dose-dependent curve, similar to what had been seen earlier with
pre-boiled FBS (compare with Fig. 3A). That is, turbidity
increased up to 0.4 mg/ml of BSA and decreased thereafter with
higher protein concentrations. With both whole FBS and HS, we
had also seen earlier evidence of protein denaturation with
prolonged boiling for 120 minutes; a turbidity increase could also
be seen readily on the first day following inoculation (Fig. 3A).
When inoculated together, BSF and BSA that had been pre-
boiled for either 10 or 30 minutes no longer produced any
precipitation even when observed after 1 month of incubation,
suggesting in inhibitory influences exerted predominantly by BSF
at the expense of BSA (Fig. 7A, ‘‘Boiled BSF+Boiled BSA’’
column). On the other hand, the addition of BSF and BSA that
had been pre-boiled for 120 minutes also gave a dose-dependent
increase in turbidity on the first day following incubation into
DMEM, presumably due to the same insolubility of boiled BSA
seen earlier. It should be further noted that the addition of both
control and untreated BSF and BSA did not produce any turbidity
change, in line with earlier results shown in Figures 4A and 5.
Together, these results indicate that BSF that had been boiled
extensively retained its inhibitory effects on mineral precipitation
in a metastable medium like DMEM, while pre-boiled BSA
appeared to seed mineral growth. The seeding induced by pre-
boiled BSA was replaced however by an inhibitory effect that was
seen at higher BSA concentrations exceeding 1.2 mg/ml (results
seen with BSA pre-boiled for 10 and 30 in). However, upon
prolonged boiling for 120 minutes, BSA lost both its slow mineral-
seeding as well as inhibitory potential.
In the presence of added calcium and phosphate, however, the
following interesting observations were obtained (Fig. 7B). Firstly,
with the addition of 1 mM calcium and phosphate alone,
precipitation appeared in DMEM immediately and gradually
increased for several days, after which it remained unchanged for
up to 1 month (Fig. 7B, only ‘‘1 Month’’ reading shown). In fact,
the readings obtained for ‘‘Day 4,’’ ‘‘Day 7,’’ and ‘‘1 Month’’ were
virtually indistinguishable (data shown only for 1 month). The
addition of control, untreated BSF produced a noticeable dose-
dependent, inhibitory effect on this same precipitation that
remained also unchanged for a period of observation of up to 1
month (Fig. 7B, row referred as ‘‘0 min Boiling Time’’).
Surprisingly, the inoculation of BSF that had been pre-boiled for
10 or 30 minutes resulted in a similar stable, dose-dependent
inhibitory effect that also remained unchanged for at least 1
month. No additional precipitation that could be attributed to
control or pre-boiled BSF was found. In contrast, BSF that had
been pre-boiled for 120 minutes displayed markedly different
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PLoS ONE | www.plosone.org 14 November 2009 | Volume 4 | Issue 11 | e8058Figure 7. Seeding of NB-like particles by boiled fetuin-A and albumin in metastable versus supersaturated medium. (A) Metastable
medium: BSF and bovine serum albumin (BSA) were boiled for the time indicated on the left side. The boiled protein solutions were then diluted into
DMEM, separately or together, to the final concentrations indicated on the top. A650 was then monitored following inoculation (‘‘Day 1’’) and after
incubation in cell culture conditions for 1 month, as indicated on the right. Inoculation of either untreated BSF or BSF that had been boiled for either
10, 30, or 120 min did not result in any turbidity changes after 1 month of incubation. In contrast, pre-boiled BSA produced either bell-shaped or
linear turbidity changes depending on the amount of boiling time. When added together, pre-boiled BSF and BSA produced additive effects. (B)
Supersaturated medium: BSF and BSA were added to medium as in (A) that was also inoculated with 1 mM each of CaCl2 and NaH2PO4. Notice the
various patterns of turbidity changes associated with the three protein combinations. See the text for further details.
doi:10.1371/journal.pone.0008058.g007
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by this boiled BSF that synergized with the precipitation produced
by the addition of 1 mM calcium and phosphate. Apparently, the
calcification-inhibitory effects attributed to BSF were at least
partially removed by this extensive boiling.
Pre-boiled BSA produced marked different results. Firstly, both
control, untreated BSA and BSA that had been pre-boiled for 10
or 30 minutes were shown to produce an immediate inhibitory
effect on the precipitation mediated by 1 mM calcium and
phosphate added to DMEM (Fig. 7B, see the ‘‘Boiled BSA’’
column in the ‘‘Day 1’’ panel). Precipitation then increased
gradually over the course of the next 3 days (not shown). With
additional incubation, the initial inhibitory effects seen associated
with both untreated and pre-boiled BSA gave way to a marked
dose-dependent increase that peaked at 1.2 mg/ml BSA (Fig. 7B).
Pre-boiled BSA produced higher levels of turbidity as compared
with control, untreated BSA (Fig. 7B). Still, in all 3 instances
(untreated BSA, or BSA that had been pre-boiled for 10 or
30 min), a somewhat inhibitory effect was seen at a BSA
concentration of 4 mg/ml. In contrast, BSA that had been pre-
boiled for 120 minutes also showed an immediate precipitation on
‘‘Day 1’’ that synergized with the precipitation induced by 1 mM
calcium and phosphate alone; this same precipitation did not
increase thereafter (compare ‘‘Day 1’’ and ‘‘1 Month’’ panels in
Fig. 7B), indicating that, as before, the turbidity seen associated
with this form of boiled BSA most likely resulted from protein
denaturation, and this denaturation may have removed both the
seeding and inhibitory potentials of this protein.
Finally, adding both pre-boiled BSF and BSA to supersaturated
DMEM containing 1 mM calcium and phosphate produced the
same additive inhibitory effects seen earlier with this type of
protein mixture (Fig. 7B, compare with similar column in Fig. 7A).
As before, it appears that the presence of BSF, be it untreated or
pre-boiled, markedly reduced the seeding potential attributed to
BSA alone.
Our results indicate that, compared to albumin, fetuin-A is
more resistant to boiling and that it is predominantly a
calcification inhibitor even in the presence of exogenously added
calcium and phosphate (e.g. in supersaturated calcium solutions).
Thus, even upon prolonged incubation for at least 1 month, these
same inhibitory effects seen with pre-boiled fetuin-A against
supersaturated solutions remained intact and appeared to
predominate over any seeding tendencies. Albumin, on the other
hand, was shown here to be less inhibitory on mineralization and it
also appeared to be more sensitive to boiling. Thus, boiled
albumin seeded minerals spontaneously, in the absence of
exogenously added calcium and phosphate. However, it is clear
that both albumin and fetuin-A, upon being boiled up to
30 minutes, retained their respective mineralization-inhibitory
capabilities, a property that was lost upon more extensive boiling
(120 min), at which point, seeding prevailed.
From our data, it can be further concluded that we have been
able to induce calcium nanoparticle seeding in a metastable
medium like DMEM with boiled albumin, but not with fetuin-A.
It should be pointed out that our initial intention was to use boiling
as a tool to unfold or denature both proteins so as to demonstrate
their mineral seeding capabilities in the context of a metastable
medium. However, in spite of repeated efforts to unfold or
denature fetuin-A using boiling as well as other treatments detailed
below, we have failed to induce mineral seeding with fetuin-A
under metastable conditions.
For instance, we attempted to immobilize either albumin or
fetuin-A, or both, onto various plastic substrates, including 24-well
plates and 96-well ELISA plates made of polystyrene or
polyvinylidine fluoride (PVDF) membranes. Earlier studies had
shown that several proteins in solution tended to inhibit the
precipitation of calcium phosphate whereas the same proteins
promoted the nucleation of calcium phosphate minerals when they
were adsorbed onto a solid substrate [97–100]. This dual effect
was attributed to the possibility that the protein in solution could
cover entirely the nascent minerals, thus masking their growing
sites and thereby inhibiting crystal growth [99,101]. On the other
hand, adsorption onto a substrate would prevent the protein from
covering the growing crystals, but would instead expose chemical
groups needed for the formation of the first crystal nucleus
[99,101]. In the case of albumin, this protein was shown to induce
collagen mineralization when present in solution at low concen-
trations whereas higher concentrations inhibited mineral forma-
tion [81,82]. Albumin also promoted the mineralization of HAP
when this mineral was coated with the protein and immersed in
metastable solutions [83,84]. In contrast to these studies, other
reports have shown that albumin would essentially inhibit
precipitation of calcium phosphate irrespective of whether it was
adsorbed onto a substrate or remained free in solution [102–112].
From these observations, it thus remained unclear how these
proteins would behave when immobilized under conditions known
to favor the growth of the putative NB in culture.
In order to verify the effect of immobilized albumin and fetuin-
A on the formation of mineral nanoparticles, we attempted to
immobilize both proteins onto a hard surface with the intention of
inducing the conformational changes required to induce mineral
formation. Immobilization was performed by either drying the
proteins onto the plates overnight, by incubating the protein
solutions overnight at 4uC, or by using cross-linking reagents like
poly-lysine or octadecyltrichlorosilane (OTS) to maximize the
immobilization of the proteins on the plate. A wide range of
protein concentrations ranging between 20 mg/ml to 40 mg/ml
was used. Coating was ascertained by washing the plates
subsequently with water or HEPES buffer and staining the plates
for protein (Materials and Methods). The wells coated with proteins
were put in contact with DMEM and incubated for several weeks
in cell culture conditions, similar to the culture of NB. In spite of
repeated attempts, none of these treatments resulted in precipi-
tation of particles directly from DMEM, even after prolonged
incubation up to 1 month and monitoring with both A650 readings
and direct microscopic examination using phase-contrast micros-
copy (data not shown). From these observations, it appeared that
the presence of fixed fetuin-A or albumin was insufficient to induce
the formation of mineral nanoparticles in metastable solutions.
Since albumin, but not fetuin-A, that had been boiled could
indeed induce mineral formation in metastable DMEM, while
neither one was able to induce mineralization when fixed onto
solid substrates, it is unclear whether our negative results here are
due to the particular experimental conditions used. More
experiments are clearly needed before a definitive conclusion
can be reached regarding the seeding capability of either protein,
especially in the case of fetuin-A.
Association of Fetuin-A and Albumin with the Mineral
Phase of Nanoparticles
The seeding experiments shown here, comparing either
untreated or boiled fetuin-A versus albumin in the presence of
small submillimolar amounts of calcium and phosphate added to
DMEM, demonstrate remarkable differences in dose-dependence,
with fetuin-A showing much greater inhibitory activity than
albumin. Along the same vein of observation, seeding appeared to
be triggered at much lower doses of fetuin-A as compared to
albumin. A functional inhibition assay developed in an earlier
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and HSA (0.3 mM versus 6 mM, respectively) when the seeding
experiment was carried out in aqueous solutions in the presence of
3 mM calcium-carbonate-phosphate ions (ref. [2]; see Fig. 19 of
that study), a result that approximates the 14-fold difference seen
with seeding experiments done in DMEM in the present study
(Figs. 5–7). In that same earlier study [2], both BSF and HSA were
seen to bind to mineral complexes in a stoichiometric manner that
could be demonstrated by means of sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE; see Fig. 21 in ref.
[2]). It is noteworthy that BSF and HSA that had been trapped by
precipitating minerals gave similar intensities when analyzed by
SDS-PAGE in spite of a 10-fold difference in their concentrations
used, indicating again a much greater affinity of these mineral
complexes for fetuin-A as compared to albumin (see Fig. 21 of ref.
[2]). These results point to a hierarchy of protein binding by
nascent apatite complexes that in turn can be predicted by the
binding affinities of the individual proteins toward calcium and
phosphate. Furthermore, they suggest that proteins present during
particle formation may tentatively become an integral part of
calcifying nanoparticles, a notion that had been advocated earlier
to explain the biology of NB ([1–3,46]; see also refs. [113,114] for
related studies).
To further ascertain that fetuin-A and albumin bind to calcium
phosphate in a stoichiometric fashion and that these two proteins
interact with each other by competing for apatite binding, we
performed the following SDS-PAGE analysis. Specifically, we
sought to use SDS-PAGE to demonstrate the marked differences
in binding affinities between these proteins and apatite. Mineral
complexes were formed in the presence of BSF, HSA, or both in
DMEM inoculated with 3 mM calcium and phosphate as before;
they were then washed and subjected to SDS-PAGE (Fig. 8A–C;
see also Materials and Methods). To facilitate referencing of the
nanoparticles studied, we used in the Figure caption the acronym
NLP, preceded by the name of the particular protein(s) used to
form them (BSF, HSA, or both, described respectively in
Figure 8A, B, and C). The NLP samples studied here were
obtained by diluting fetuin-A and/or albumin into DMEM at the
final concentrations of 20–160 mg/ml for BSF and/or 0.2–
1.6 mg/ml for HSA, followed by the addition of the calcium
and phosphate ions to a final concentration of 3 mM. Incubation
was done in cell culture conditions for 1 month, during which time
mineral precipitates appeared gradually that were then sediment-
ed, washed, and processed for gel electrophoresis and Coomassie
blue staining.
In the case of BSF-NLP, an increase in protein band intensity
was seen in direct proportion to the amount of BSF present in the
incubation medium leading to mineral precipitation (Fig. 8A).
Fetuin-A appeared initially as a single band slightly above 72 kDa
(Fig. 8A, lane 1), but additional higher and lower bands could be
distinguished when higher amounts of protein-mineral precipitate
were electrophoresed under the same conditions (Fig. 8A, lanes
2–4). It should be pointed out that even though fetuin-A has a
predicted molecular weight of 48 kDa, it is known to migrate to a
higher molecular weight under denaturing and reducing condi-
tions similar to what were used here, an observation that had been
attributed earlier to the heavy glycosylation of this protein [115].
Furthermore, we have found that the migration of fetuin-A may
vary with the commercial source of the lot as well as with the
particular electrophoresis conditions used (for example, see Fig. 14
of ref. [2] for comparison). Notably, the higher molecular weight
bands seen associated with fetuin-A (Fig. 8A, lane 4) were probably
the result of aggregation in the presence of apatite, especially since
control, untreated fetuin-A failed to show them (data not shown).
In the case of HSA-NLP, obtained using a 10-fold higher
concentration of protein as compared to BSF-NLP (0.2–1.6 mg/
Figure 8. Differences in the binding affinities between fetuin-A and albumin toward NB-like particles as revealed by SDS-PAGE. NB-
like particles were prepared from 3 mM each of CaCl2 and NaH2PO4 in 1 ml of DMEM containing either BSF, HSA, or both proteins at the following
concentrations: 20 mg/ml, 40 mg/ml, 80 mg/ml, or 160 mg/ml of BSF, corresponding respectively to lanes 1–4 in (A); 0.2 mg/ml, 0.4 mg/ml, 0.8 mg/ml,
and 1.6 mg/ml of HSA, respectively, lanes 1–4 in (B); or both proteins at these same concentrations for lanes 1–4 in (C), respectively. Following
incubation in cell culture conditions for 1 month, the NB-like particles were pelleted by centrifugation, washed twice in HEPES buffer, resuspended in
50 ml of 50 mM EDTA, and processed for SDS-PAGE as described in the Materials and Methods. In the case of BSF-NLP shown in (A), fetuin-A appeared
as a major band slightly above 72 kDa (lane 1), with additional bands of higher and lower molecular weights noticeable at higher protein
concentrations (lanes 2 to 4). In HSA-NLP (B), albumin formed a major band of strong intensity at 72 kDa. Note a higher molecular band above the
170 kDa marker that appears to increase steadily from lanes 1 through 4, while the 72 kDa band in the 4 lanes appears to decrease slightly in intensity
from left to right. In the case of BSF-HSA-NLP (C), note the increase in the intensity of bands at 72 kDa and at a higher molecular weight. The bands of
higher molecular weights may be due to altered migration or aggregation of the purified proteins used.
doi:10.1371/journal.pone.0008058.g008
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samples analyzed showed a major band of 72 kDa. A dose-
dependent increase in the intensity of this major band was not
apparent, indicating that saturating doses of albumin must have
been used here. On the other hand, with an increase in albumin
input used for the formation of HSA-NLP, there was a noticeable
dose-dependent increase of higher molecular weight bands (over
150 kDa) that appeared to correspond to aggregated/polymerized
protein species (Fig. 8B, lanes 1–4). In fact, we chose to use these
saturating amounts of albumin in order to assess more clearly the
inhibition produced by fetuin-A, as follows.
Figure 8C depicts the gel profile of various amounts of BSF-
HSA-NLP formed in the presence of both BSF and HSA in the
same amounts described above. There was a noticeable decrease
in band intensity as compared with Figure 8B, indicating that
albumin incorporation into the mineral complex had been
significantly reduced. Since albumin had been used in excess in
these experiments and exceeded the amount of fetuin-A by at least
10 fold, these results indicate clearly that the binding of fetuin-A to
the mineral particles was not only significantly stronger than that
seen for albumin, but that its binding to apatite appeared to
compete off or inhibit the simultaneous binding by albumin.
Nonetheless, it is also clear that both BSF and HSA appeared to
have been incorporated into the particles, since the gel pattern
seen with BSF-HSA-NLP appeared to incorporate characteristics
of both BSF-NLP and HSA-NLP (compare the 3 gel profiles
shown in Fig. 8). However, it is obvious from inspecting this gel
profile that albumin only appeared to incorporate into the same
mineral complexes at the higher doses used (0.8 and 1.6 mg/ml,
lanes 3 and 4, Fig. 8C), whereas at the lower doses (0.2 and
0.4 mg/ml, lanes 1 and 2, Fig. 8C), only fetuin-A binding
appeared to be more noticeable. Note also that in the presence of
fetuin-A and albumin, the higher molecular weight bands
appeared to migrate differently from those obtained with either
protein alone—a result that perhaps suggests in further interac-
tions between the two proteins when they were present together in
the same complex. Given however that the two proteins migrated
with overlapping molecular weights, the interpretation given here
must be viewed with caution and must be considered along with
the bulk of the functional data presented in the earlier sections in
this study and elsewhere [2].
The data presented here show further that, on the one hand,
proteins like fetuin-A and albumin appear to inhibit the formation
of calcium nanoparticles, and, yet, they eventually incorporate into
the same mineral nanoparticles that they attempt to inhibit in the
first place. Moreover, our results clearly indicate that there is
indeed a hierarchy in terms of preferential incorporation of
proteins into the nanoparticle scaffold, a preference that is dictated
by the differential binding affinities displayed by the proteins
themselves. Fetuin-A, for one, binds more strongly to apatite
minerals than albumin [2,74], and thus it is a much more potent
inhibitor of mineralization that in turn seems to interfere with
concomitant albumin incorporation. Finally, these binding
(inhibitory) processes appear to be transient, and, upon prolonged
incubation, there is a gradual overcoming of this inhibition that
yields to particle growth and seeding.
Protein-Mineral Nanoparticles Show Morphological
Resemblance to Both Serum Granules and Cultured NB
In order to verify whether the mineral nanoparticles formed in
the presence of fetuin-A or albumin in DMEM supplemented with
exogenous calcium and phosphate (supersaturated solutions)
represent particles similar to the purported NB as well as the
earlier calcium granules found in the serum [1–3], we used a series
of electron microscopy techniques with high-resolution capabili-
ties. NLP representative of the experiments described in this study
(Figs. 4–6) were prepared by adding 0.3 mM each of calcium and
phosphate to DMEM containing either BSF at 2.1 mg/ml (Fig. 9A
and D, labeled as ‘‘BSF-NLP’’), HSA at 120 mg/ml (Fig. 9B and E,
‘‘HSA-NLP’’), or both BSF and HSA in these same concentrations
(Fig. 9C and F, ‘‘BSF-HSA-NLP’’), followed by incubation in cell
culture conditions. These protein concentrations were selected to
match maximal mineral precipitation as evidenced earlier from
experiments depicted in Figure 6 (0.3 mM column). Samples were
then prepared for scanning electron microscopy (SEM) as
described in the Materials and Methods.
Mineral particles seeded by fetuin-A and/or albumin retained
round morphologies that could be seen after 3 days of incubation
(Fig. 9A–C; data not shown for shorter incubations). Examined
after 3 days of incubation, the particles prepared in the presence of
fetuin-A and/or albumin were comparable while showing great
heterogeneity in sizes, varying between 50 to 1,000 nm in
diameter (Fig. 9A–C). However, we noticed that shorter
incubation periods revealed that the fetuin-A particles were in
fact smaller in size. Thus, by means of dynamic laser scattering
(DLS), we have seen that BSF-NLP freshly formed in the presence
of 2 mg/ml of BSF in 1 mM of calcium and phosphate in DMEM
gave an average size of 123 nm vs. an average size of 479 nm for
HSA at 2 mg/ml incubated under similar conditions (data not
shown). In contrast, in the presence of 1 mM calcium and
phosphate added to DMEM but in the absence of proteins, the
particle size obtained immediately after mixture averaged
1,631 nm. Particle size observed under these conditions was
clearly a function of incubation time and by 24 hours at room
temperature, the particle sizes of BSF-NLP averaged 227 nm,
HSA-NLP 720 nm, and NLP-devoid-of-proteins 4,810 nm (un-
published observations).
With further incubation, particle sizes grew further and while
the fetuin-A-particles appeared to lag behind in size as compared
with albumin-particles, this difference became less noticeable, and
by the 3
rd day of incubation, their sizes became somewhat
comparable. Moreover, with the passage of time, particles were
seen to fuse together, forming structures that resemble dividing
bacteria. However, contrary to the earlier assumptions that these
formations might represent dividing bacteria [4,5,7–9], it appears
more plausible that they form from the growth of two independent
mineral particles that fuse and coalesce as they continue to expand in
size. Alternatively, a fully formed particle with rounded shape may
presumably also serve as a template for the growth of a second
particle and result in formations that may resemble dividing
microorganisms.
When particles incubated for the longer period of 1 month
were observed by SEM, we noticed that the round mineral
nanoparticles had converted into more crystalline films and
mattresses, harboring spindles and projection-prone crystals, at
which point round particles could either no longer be distin-
guished or were rare by comparison (Fig. 9D–F, note the
differences in morphologies with the corresponding particles
shown in Fig. 9A–C).
Particles formed under different mineral:protein ratios showed
distinct features, with smaller sizes being seen at higher protein
concentrations while films and aggregates predominated with
higher mineral-to-protein ratios—with the latter conditions
favoring a significantly faster particle-to-film conversion (data
not shown).
We compared the morphology of the particles seeded in the
presence of proteins with the calcium granules obtained earlier
from the serum [3]. These calcium granules were prepared by
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Na2HPO4 (Fig. 9H), or, still, with both calcium and phosphate to a
final concentration of 2 mM each (Fig. 9I). These calcium granules
were shown earlier to display morphologies and chemical
compositions identical to the purported NB described in the
literature, allowing for the possibility that they may represent
universal structures found throughout nature and with potential
role in pathogenesis if overtly accumulated in the body [3]. As
shown in Figure 9G–I, these same calcium granules showed
variable morphologies depending on the amounts of ions added or
the time of incubation used, with initial serum precipitations
appearing mostly as round nanoparticles with calcium loading
(Fig. 9G), and showing more crystalline appearance when either
phosphate or calcium and phosphate were added (Fig. 9H and I,
respectively), all of which appeared indistinguishable from the
protein-mineral complexes studied here. Thus, following incuba-
tion, there was a gradual conversion of round particles to spindle
and film shapes, a conversion that was evident with both protein-
mineral complexes and serum granules.
In order to further ascertain that these protein-mineral particles
were similar to the NB described earlier, we used ‘‘NB strains’’
obtained and cultured from several different sources. Thus, ‘‘HS-
NB’’ were obtained from healthy human blood by diluting whole
serum in DMEM at 10% and incubating the solution in cell
culture conditions for two months (Fig. 9J). We also used other
cultures of NB obtained initially from 10% FBS and that had been
extensively characterized by other authors [5,8,9]. In fact, the first
‘‘strain’’ of NB, obtained from FBS, was deposited by Kajander
and his colleagues, the discoverers of NB, with the German
Collection of Microorganisms (referred as ‘‘DSM 5820’’ in the
figures presented in the present study) while another one
represented a culture initially named Nanobacterium sp. Seralab
Figure 9. Protein-mineral nanoparticles seeded by fetuin-A and albumin show morphological resemblance to NB and calcium
granules when observed by SEM. Protein-mineral nanoparticles were prepared by adding 0.3 mM of CaCl2 and NaH2PO4 to DMEM containing
BSF at 2.1 mg/ml (A and D, labeled as ‘‘BSF-NLP’’), HSA at 120 mg/ml (B and E, ‘‘HSA-NLP’’), or both BSF and HSA at these same concentrations (C and F,
‘‘BSF-HSA-NLP’’), followed by incubation for either 3 days (A–C) or 1 month (D–F) in cell culture conditions and preparation of the particles for TEM, as
described in the Materials and Methods. Protein-mineral nanoparticles containing BSF and/or HSA showed a round morphology when observed after
3 days (A–C), but they tended to coalesce to form films or aggregates when incubated for a longer period of 1 month (D–F). Note the presence of
structures resembling cells undergoing cell division in (B). Calcium granules were prepared from the addition of either CaCl2 (G), NaH2PO4 (H), or a
combination of both (I) to FBS, followed by overnight incubation, centrifugation, and the washing steps described in the Materials and Methods.
Calcium granules showed variable morphologies, consisting of either round particles (G) or film/aggregate-like structures (H and I). The morphologies
of both the protein-mineral nanoparticles and the calcium granules were similar to NB obtained from 10% HS (J, ‘‘HS-NB’’) or the NB strains ‘‘Nanons’’
(K) and ‘‘DSM 5820’’ (L) which were both maintained in 10% FBS. These NB samples revealed either round particles (J and K) or more crystalline
structures harboring elongated crystal projections and aggregates (L). Scale bars: 100 nm (F, I); 200 nm (A, C–E, G, H, J, L); 400 nm (B); 1 mm (K).
doi:10.1371/journal.pone.0008058.g009
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Raoult et al. as ‘‘nanons’’ [46]. Both ‘‘strains’’ had been
maintained in 10% FBS prior to being processed for SEM. NB
obtained from 10% HS (Fig. 9J) or the NB strains ‘‘Nanons’’
(Fig. 9K) and ‘‘DSM 5820’’ (Fig. 9L), showed morphologies that
varied from round to spindle and film shapes, accompanied by
varying degrees of crystallinity. For instance, while the HS-NB
showed predominantly smooth round particle shapes, ‘‘nanons’’
were larger and showed surface crystalline ridges, and ‘‘DSM
5820’’ had a mixture of irregular particles and spindles with more
irregular crystalline projections. It should be noted however that
the particle morphologies seen here could be easily modulated by
the frequency of serial passages as well as the amount of inoculated
serum. In general, the older cultures appeared more crystalline
and film-like while the frequently passaged cultures showed
predominantly round particles. From these studies, it can be
concluded that, from a morphological point-of-view, the protein-
mineral complexes assembled from purified components are
virtually indistinguishable from the serum granules and the so-
called NB that had been characterized earlier.
A morphological resemblance between the various structures
studied here could be further ascertained by transmission electron
microscopy (TEM). Under TEM, BSF-NLP revealed small
aggregated particles with rounded shapes. The surface of the
particles obtained after 3 days of incubation appeared more
crystalline under TEM than when examined earlier by SEM
(Fig. 10, compare the surface of the particles shown after 3 days of
incubation, which seemed to be irregular and of different electron
densities under TEM in Fig. 10A–C whereas the same particles
appear to have a smoother surface under SEM in Fig. 9A–C). By
analogy, in a recent study on the mineralization of fin from
zebrafish in which the exact same sample area was examined by
both TEM and SEM [116], the authors also noticed a greater
tendency of TEM images of mineral deposits to reveal a more
crystalline nature as compared with SEM, similar to what we have
also observed with our own NB/NLP samples.
Figure 10. Protein-mineral nanoparticles containing fetuin-A and albumin resemble NB and calcium granules as revealed by TEM.
Protein-mineral nanoparticles were prepared as described in Fig. 9, from solutions containing either BSF (A), HSA (B), or both proteins (C), followedb y
the addition of 0.3 mM each of CaCl2 and NaH2PO4, and incubation for 1 month in cell culture conditions. The samples were then prepared for TEM
without fixation or staining. The various protein-seeded particles showed small, rounded formations that tended to aggregate (A–C). The samples of
calcium granules prepared from addition of either CaCl2 (D), NaH2PO4 (E), or a combination of both (F) to FBS (see Materials and Methods) showed
stacks of crystalline spindles and stacks forming ellipsoid structures (D and E), while other granules appeared mostly as round aggregated particles
(F). The morphologies of the protein-mineral nanoparticles and the calcium granules were similar to NB obtained from either 10% HS (G, ‘‘HS-NB’’) or
the two NB strains ‘‘Nanons’’ (H) and ‘‘DSM 5820’’ (I) which were both obtained from 10% FBS. In this case, the NB samples consisted of rounded
particles with rough surfaces and variable sizes (G–I). Commercially available CaCO3 (J), Ca3(PO4)2 (K), and HAP (L) incubated in DMEM for 1 hour
showed mainly large, crystalline, monolithic structures. Scale bars: 50 nm (A, F); 100 nm (B, D, E, G–J, L); 200 nm (C, K).
doi:10.1371/journal.pone.0008058.g010
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form spindles (Fig. 10D–F) as compared to protein-based NLP
(Fig. 10A–C). In comparison, the morphologies of both the BSF-
NLP and HSA-NLP were remarkably similar to those of NB
obtained from either 10% HS (Fig. 10G, ‘‘HS-NB’’) or the two NB
strains ‘‘Nanons’’ (Fig. 10H) and ‘‘DSM 5820’’ (Fig. 10I). Like the
protein-NLP, all NB specimens showed rough surfaces with
crystalline appearance. NB that had been obtained shortly after
serial passages were comparable in sizes and surface characteristics
to the protein-mineral complexes studied here and ranged
between 20 to 500 nm (Fig. 10G–I, compare the sizes of the
particles in Fig. 10A–C).
In support of these observations, the earlier electron diffraction
patterns obtained in conjunction with TEM of calcium granules
and the purported NB showed a predominance of polycrystalline
structures compatible with the presence of amorphous aggregates
undergoing varying degrees of crystallization [2,3]. Virtually
identical patterns were obtained with the protein-mineral
complexes studied here (data not shown). That is, polycrystalline
materials with relatively low degrees of crystallinity could be seen
to be associated with BSF-NLP, HSA-NLP, and BSF-HSA-NLP
(data not shown).
These results indicate that the simultaneous amorphous-
crystalline attributes of NLP appear to represent examples of a
wide spectrum of possibilities within the chemical composition
repertoire associated with these mineral aggregates. Our results
would indicate that the amorphous nature of these particles is
enhanced by the presence of proteinaceous factors and possibly
other organic compounds found in the serum. Regardless, there
appears to be a gradual and irreversible progression or conversion
from amorphous to crystalline phases within the same calcified
samples. Given the repeated findings of both amorphous and
crystalline phases in our samples, along with a wide array of
intermediate states, our interpretation appears to offer a
reasonable explanation for the assembly of calcifying nanoparticles
both in vitro and in vivo. In fact, the recent breakthrough study using
zebrafish fin as a model for biomineralization does point in fact to
this same conclusion for mineralization processes seen in living
tissues [116].
As additional controls, commercial compounds of CaCO3
(Fig. 10J), Ca3(PO4)2 (Fig. 10K), and HAP (Fig. 10L) were similarly
incubated in DMEM prior to their being processed for TEM (only
data for 1 hour incubation shown here; longer, overnight
incubations resulted in a predominance of crystalline, monolithic
structures). This additional incubation in DMEM was done to
ensure that these control compounds would be subjected to the
same culture conditions used here, with the exception that neither
whole serum nor serum proteins were present. It should be further
noted that DMEM is known to contain a wealth of ions, amino
acids, and other compounds needed for the sustenance of cultured
cells, exemplifying an environment that is most likely to be found
in vivo; in turn, the charged and organic substrates contained in
DMEM may very well modulate the assembly of nanoparticles!
Control samples prepared in this manner (e.g. in the presence of
DMEM) showed morphologies that were different from the
various protein-mineral complexes, calcium granules, and NB
samples shown. Irregular aggregates, platelets, and larger masses
of crystals were seen that were devoid however of smaller round
nanoparticles (Fig. 10J–L). From these experiments, it would
appear that, if round nanoparticles were present in such
preparations of commercial compounds, they must be short-lived
compared to the other samples examined. It is also possible that in
the absence of proteins and other organic compounds found in the
serum, the round particles rapidly collapse or coalesce to form
larger platelets, films, and aggregates. In fact, earlier studies done
by Nylen, Eanes, and Termine had shown that calcium and
phosphate solutions, in the absence of any organic compounds,
undergo rapid conversion from round particles to platelets and
then to larger aggregates within a few hours [117,118].
Thin-Section Electron Microscopy of Fetuin-A and
Albumin-Containing Nanoparticles Reveal Unique
Morphologies
Next, thin-sections of the protein-mineral particles were
prepared in order to compare their internal structures with those
of the NB-like formations and calcium granules characterized
earlier. Protein-mineral particles were prepared by using BSF and
HSA as well as precipitating ions at concentrations that favored
maximal precipitation as described earlier in Figure 6. In this case,
calcium and phosphate were added each at 0.3 mM to DMEM
containing either BSF at 2.1 mg/ml, HSA at 120 mg/ml, or both
BSF and HSA at these same concentrations, followed by
incubation in cell culture conditions and preparation of thin-
sections as described in the Materials and Methods.
As shown in Figure 11, large BSF-NLP around 1 mmi n
diameter tended to show variegated, multi-layered structures with
alternating electron dense and pervious laminations resembling at
times ‘‘bull’s eyes’’ or ‘‘tree-age-ring-like’’ morphology typical of
NB [3,5,27] as well as calcium granules found in the serum [3] and
throughout nature (see the galleries of granule pictures assembled
by Ryall [51]). In this case, the dark rings appeared to consist
mainly of crystalline material (Fig. 11B and C). In fact, dark,
crystalline needle-like projections could also be seen to protrude
transversally from either the surface or from the core interior (see a
magnified image in Fig. 11C). Like the many calcium granules
found in nature [51], the alternating electron dense and pervious
layers found here can also be interpreted as representing
intercalated layers of mineral and organic matrices, or alterna-
tively, they may represent distinct stages of nucleation and growth.
That is, the multi-ring formations may represent the result of
several successive cycles of growth-and-inhibition of the apatite
crystals formed in the presence of organic material, in this case
fetuin-A. Not surprisingly, inhibitors of calcification like osteo-
pontin, as well as other proteins like alpha-anti-trypsin, were
shown to be present at the mineral-protein interface within the
multi-layer particles found in kidney tissues [119–125].
When albumin was used instead to seed mineral particles in
supersaturated solutions, the particles showed morphologies that
were significantly different from those of the fetuin-A-NLP seen
earlier. Noticeably, HSA-NLP were less likely to form multi-
layered structures. Instead, they tended to adopt morphologies
resembling incomplete, single-layered rings consisting of electron-
dense spindles or needle-like projections surrounding a core
material that appeared more electron-pervious (Fig. 11D–F).
Assuming that the outer, dark, electron-dense layer represents a
mixture of organic and mineral interphases, as interpreted from
the vast literature on calcium granules [51,119–126], it is possible
that the incomplete rings seen associated with HSA-NLP may
represent incomplete enclosure or inhibition of nascent apatite!
That is, albumin, being a much less potent inhibitor of
mineralization than fetuin-A, may not be capable of inhibiting
fully the nucleation of nascent apatite crystals, and this in turn can
be translated further into the predominance of incomplete rings
seen in Figure 11D–F. Assuming that this reasoning is correct, it
can be further inferred that, during the process of nanoparticle
assembly, the presence of organic inhibitors actually helps sustain
the rounded shapes of nanoparticles, thereby delaying or
repressing their conversion into larger aggregates and films.
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presence of both fetuin-A and albumin (Fig. 11G–I) assumed a
variety of shapes, including multi-layered formations (Fig. 11G)
and single-walled rings (Fig. 11I). Intriguingly, the incomplete
rings seen earlier with HSA-NLP were not found among the BSF-
HSA-NLP samples. As before, electron-dense, crystalline, needle-
like projections could be seen protruding from the rings (Fig. 11H
and I). It should be noted that we used combinations of BSF and
HSA here at concentrations that favored maximal mineral
precipitation as seen in Figure 6, indicating that these images
may correspond in fact to optimal protein-mineral interactions
that lead to mineralization.
As controls, commercially available CaCO3 (Fig. 11J),
Ca3(PO4)2 (Fig. 11K), and HAP (Fig. 11L), were each diluted
and incubated in DMEM for various amounts of time, and
processed for thin-section TEM (only data for 1 hour incubation
shown here). As can be seen from Figure 11J-L, these same
controls appeared as large homogeneous and monolithic crystal-
line formations, lacking the characteristic round and multi-layered
morphologies linked otherwise to the protein-mineral nanoparti-
cles. Longer incubations of these control compounds in DMEM
resulted in further homogenization and consolidation of the
aggregates (not shown). These results further indicate that the ring-
like structures, be them complete and multi-layered, or incomplete
and single-walled, may correspond to organic-mineral interphases
that are in turn absent when formed in protein-free medium that
had been supplemented with precipitating minerals.
Chemical Composition of Nanoparticles Formed by
Fetuin-A and Albumin in Supersaturated Ionic Solutions
To further study the chemical composition and characteristics
of the protein-mineral nanoparticles formed in DMEM containing
supersaturated amounts of precipitating ions, we used several types
of spectroscopy. Earlier studies had shown that both NB-like
specimens as well as serum calcium granules could be character-
ized as carbonate HAP ([2,3]; see also the earlier study by
Kajander and Ciftcioglu [5]), a type of mineral similar to that
found in bones as well as in ectopic calcification [127,128]. We
Figure 11. Thin-sections of protein-mineral nanoparticles seeded by fetuin-A or albumin show distinct morphologies. Protein-mineral
nanoparticles were prepared as described in Fig. 6, by diluting either BSF at 2.1 mg/ml (A–C), HSA at 120 mg/ml (D–F), or both proteins at these same
concentrations (G–I) into DMEM and then adding 0.3 mM each of CaCl2 and NaH2PO4, followed by incubation in cell culture conditions for 1 month.
Thin-sections were prepared without fixation or staining, as described in the Materials and Methods. BSF-NLP (A–C) resembled multi-layered
laminations with alternate electron densities. HSA-NLP (D–F) appeared mostly as incompletely sealed, single-layered formations. The BSF-HSA-NLP
particles had rough surfaces covered with elongated crystal projections (G), with some structures appearing either as multi-layered (H) or single-
layered (I). Control, commercial grades of CaCO3 (J), Ca3(PO4)2 (K), and HAP (L) were incubated in DMEM as in Fig. 10. These controls showed mainly
monolithic platelets or aggregates of crystalline formations that contrasted with the round nanoparticles shown above. Scale bars: 100 nm (H, I, L);
200 nm (C, K); 250 nm (F); 500 nm (B, D, E, G, J); 1 mm (A).
doi:10.1371/journal.pone.0008058.g011
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fetuin-A or albumin might reveal these same chemical character-
istics so as to demonstrate that such simple protein-mineral
complexes may indeed reproduce all the structural characteristics
attributed to NB and calcium granules.
We first used energy-dispersive X-ray spectroscopy (EDX) in
order to determine the elemental composition of the mineral phase
associated with the protein-containing particles. As seen in
Figure 12, the mineral nanoparticles seeded by BSF and/or
HSA (labeled as ‘‘BSF-NLP,’’ ‘‘HSA-NLP,’’ and ‘‘BSF-HSA-
NLP’’) mainly showed peaks of calcium (Ca) and phosphorus (P)
(Fig. 12A–C, compare their signals with those obtained for the
control samples of CaCO3,C a 3(PO4)2, and HAP shown in
Fig. 12J, K, and L, respectively).
Peaks corresponding to carbon (C) and oxygen (O) were also
observed in the protein-mineral particles, indicative of the
presence of carbonate; in fact, in the experiments shown in
Figure 12A–C, the oxygen:carbon ratios obtained for these three
samples varied between 2.41 to 3.23, close to the ratio of 3
expected for carbonate. The intensities of the C and O peaks also
Figure 12. Energy-dispersive X-ray spectroscopy of protein-mineral nanoparticles shows elemental compositions indistinguishable
from those of calcium granules and NB. Protein-mineral nanoparticles were obtained as in Fig. 9, from solutions containing BSF (A), HSA (B), or
both (C), to which 0.3 mM each of CaCl2 and NaH2PO4 was added, followed by incubation in cell culture conditions for 1 month. EDX spectra were
also obtained for calcium granules prepared by adding either CaCl2 (D), NaH2PO4 (E), or a combination of both (F) to FBS, followed by overnight
incubation, centrifugation, and washing, as described in the Materials and Methods. NB were cultured from 10% HS (G, ‘‘HS-NB’’) or from 10% FBS (H
and I, corresponding to ‘‘Nanons’’ and ‘‘DSM 5820’’, respectively). In these specimens, major peaks of carbon, oxygen, calcium, and phosphorus were
noted, concordant with the presence of a calcium phosphate mineral containing carbonate. The three controls CaCO3 (J), Ca3(PO4)2 (K), and HAP (L),
diluted and washed in double-distilled water, were shown for comparison. The following Ca/P ratios were obtained: (A) 1.37; (B) 1.53; (C) 1.6; (D) 1.32;
(E) 1.48; (F) 1.14; (G) 1.48; (H) 1.4; (I) 1.27; (K) 2.54; and (L) 1.48. Phosphorus was not detected in the CaCO3 samples shown in (J).
doi:10.1371/journal.pone.0008058.g012
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within the same sample. Thus, consistently, we found that fresh
samples of BSF-NLP or HSA-NLP contained more carbonate,
while aged samples (after 1 week) contained predominantly
calcium and phosphate—results that are consistent with earlier
findings made on NLP and granules formed in the presence of
whole serum [2,3].
Occasionally, elements like sodium (Na), magnesium (Mg), and
chlorine (Cl) were also detected in low amounts (Fig. 12A–C). As
such, they can probably be interpreted as minor constituents of
the protein-mineral particles, or, alternatively, as unrelated
contaminants.
Overall, the EDX spectra obtained for the protein-mineral
particles (Fig. 12A–C) were indistinguishable from those of calcium
granules prepared in FBS (Fig. 12D–F) or the various NB controls
cultured from either 10% HS or 10% FBS (Fig. 12G–I). That is, the
main elements present in these samples also consisted of calcium and
phosphorus, and to a lesser extent carbonate (Fig 12D–I). The
calcium:phosphorus (Ca:P) ratios obtained for the protein-mineral
particlesvaried between 1.37 to 1.60 (Fig. 12A–C)and were similar to
the ones found for calcium granules and NB (shown in Fig. 12D–I,
with Ca:P ratios varying between 1.14 to 1.48; see also refs. [3,5]).
Carbon and oxygen peaks (e.g. carbonate) as well as minor elements
corresponding to copper (Cu) and aluminum (Al) were also noted at
times in these samples (Fig. 12D–I).
As additional controls, we also included various chemically
defined and commercially available compounds that were
incubated and washed in DMEM (Fig. 12J–L). This treatment
resulted in a slight widening of the signal peaks as compared to
those obtained with the compounds dissolved in water (data not
shown; compare with data shown in refs. [2,3]), but the peak signal
strengths were otherwise largely comparable.
Next, we used Fourier-transformed infrared spectroscopy
(FTIR) in order to identify the main functional groups found in
the protein-mineral particles, with a view toward assessing the
similarities between these particles and the previously character-
ized calcium granules and NB. For the particles prepared in
supersaturated solutions containing BSF and/or HSA, the FTIR
spectra showed mainly peaks corresponding to phosphate and
carbonate (Fig. 13A–C, compare the signals obtained with those
seen in the controls of CaCO3,C a 3(PO4)2, and HAP shown in Fig,
13J, K, and L, respectively). Phosphate peaks were observed at
wavelengths of 575 cm
21, 605 cm
21, 960 cm
21, and 1,000–
1,150 cm
21 (Fig. 13A–C; see also refs. [129,130]). Carbonate
groups, on the other hand, were detected at 875 cm
21 and near
1,400–1,430 cm
21 (Fig. 13A–C; see also refs. [131,132]). Some
peaks seen in the controls were rarely observed in the protein-
mineral particles. For example, note the presence of a carbonate
peak at 650 cm
21 in the CaCO3 control shown in Figure 13J
that was absent in the protein-mineral particles shown in
Figure 13A–C.
In addition to the phosphate and carbonate signals, a peak
corresponding presumably to the chemical bonds found in
proteins were also detected in the protein-mineral particles. Thus,
a peak corresponding to amide I was noticed at 1,660 cm
21
(Fig. 13A–C; see refs. [127,133]). However, we also observed that
the same peak corresponding to amide I at 1,660 cm
21 might also
overlap with a peak corresponding to water that was found at
1,650 cm
21 in the control specimens prepared in the absence of
proteins (Fig. 13K and L; see also refs. [134,135]). We noticed that
the peaks corresponding to amide II and III at 1,550 cm
21 and
1,250 cm
21, respectively, were usually not present in the protein-
mineral particles, possibly due to the relatively low amount of
proteins in these samples (Fig. 13A–C, see also refs. [127,133]).
Figure 13. Fourier-transformed infrared spectroscopy of
protein-mineral nanoparticles reveals the presence of both
carbonate and phosphate. Protein-mineral nanoparticles were
obtained as described in Fig. 9, by diluting BSF (A), HSA (B), or both
proteins (C) into DMEM, then adding 0.3 mM each of CaCl2 and
NaH2PO4, and incubating the solutions in cell culture conditions for 1
month. Calcium granules were prepared by adding either CaCl2 (D) or
NaH2PO4 (E) into FBS, or a combination of both CaCl2 and NaH2PO4 (F)
into HS, as described in the Materials and Methods. NB were cultured
from 10% HS (G, ‘‘HS-NB’’) or 10% FBS (H and I, corresponding to
‘‘Nanons’’ and ‘‘DSM 5820’’, respectively). The FTIR spectra of the
protein-mineral nanoparticles revealed peaks similar to both calcium
granules and NB as shown by the presence of phosphate peaks at
575 cm
21, 605 cm
21, 960 cm
21, and 1,000–1,150 cm
21 as well as
carbonate peaks at 875 cm
21 and 1,400–1,430 cm
21. Some of the
peaks corresponding to phosphate or carbonate were not detected in a
few calcium granule samples such as the one shown in (D). In the
various nanoparticle samples presented here, peaks corresponding to
amide I, II, and III at 1,660 cm
21, 1,550 cm
21, and 1,250 cm
21,
respectively, were observed and were attributed to the presence of
serum proteins. Spectra for the controls CaCO3 (J), Ca3(PO4)2 (K), and
HAP (L), diluted and washed in double-distilled water, were included as
controls. Residual water (H2O) was observed at 1,650 cm
21 in some
controls prepared in the absence of proteins (K and L); this peak could
also have contributed to the intensity of the amide I peak seen at
1,660 cm
21 in the other samples shown.
doi:10.1371/journal.pone.0008058.g013
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(Fig. 13A–C) were similar to those of calcium granules prepared in
serum (Fig. 13D–F) or the NB controls cultured from either 10%
HS (Fig. 13G) or 10% FBS (Fig. 13H and I). That is, the spectra
obtained for these samples consistently showed major peaks of
phosphate and carbonate along with peaks corresponding to
amide bonds found in proteins. Still, minor differences were noted
between these samples. For instance, some samples of calcium
granules such as the one shown in Figure 13D appeared to lack
peaks of phosphate at 575 cm
21, 605 cm
21, and 960 cm
21 and a
peak corresponding to carbonate also went missing at 875 cm
21.
The phosphate peak observed for this particular sample of calcium
granules at 1,000–1,150 cm
21 was also of lower intensity
(Fig. 13D). In addition, both the calcium granules and NB
specimens generally displayed a more prominent amide I peak as
compared to the protein-mineral particles (compare the intensity
of the amide I peak at 1,660 cm
21 in A–C with the same peak
shown in D–I). This difference in the intensity of the amide I peak
may simply reflect the fact that the calcium granules or NB were
either prepared or seeded with whole serum while the protein-
mineral particles were assembled in lower amounts of purified
proteins. Consistent with this interpretation, the calcium granules
and NB specimens displayed additional peaks corresponding
respectively to amide II at 1,550 cm
21 (Fig. 13D–F, G, and I) and
amide III at 1,250 cm
21 (Fig. 13I) that were not readily noticed
with the protein-mineral samples.
For the control compounds, we also noted the presence of
carbonate peaks associated with the calcium phosphate sample
(Fig. 13K, where carbonate peaks can be seen at 875 cm
21 and
1,400–1,430 cm
21). These peaks might be due to the prolonged
contact with ambient CO2 from air. In spite of these differences, it
can be concluded that the protein-mineral particles studied here
by FTIR can largely mimic both calcium granules and NB
preparations, indicating close if not identical structural relation-
ships between all these three types of entities.
We confirmed the presence of the major functional groups seen
here with FTIR analysis by performing micro-Raman spectrosco-
py. As can be seen from the micro-Raman spectra shown in
Figure 14A–C, the mineral particles prepared in supersaturated
solutions containing fetuin-A and/or albumin revealed mainly
peaks of phosphate at 440 cm
21, 581 cm
21, and 962 cm
21 as well
as carbonate peaks at 1,080 cm
21. However, unlike the FTIR
spectra and compared to the signals obtained for the control
compounds (Fig. 14J–L), there was a clear dampening of signals
seen with all the specimens of protein-NLP, calcium granules, and
NB—a result that could be due to the presence (and interference)
of proteins in the particle scaffold, a possibility that was pointed
out earlier [3]. That is, the green laser used to study the Raman
scattering effect makes the proteins fluoresce and such fluorescence
usually dampens the signal that can be detected from the sample,
thereby producing a high background and a low signal-to-noise
ratio [127]. Possibly for this same reason, the phosphate and
carbonate peaks were often found absent or markedly reduced
from the micro-Raman spectra obtained from the various protein-
NLP samples, as illustrated by Figure 14B and C, where there is
the absence of the carbonate peak at 1,080 cm
21 (Fig. 14B) or of
any substantial peak (Fig. 14C). Furthermore, some peaks that
were present in the controls were rarely seen in the protein-NLP
samples (BSF-NLP, HSA-NLP or BSF-HSA-NLP) such as the
carbonate peaks seen in at 280 cm
21 and 712 cm
21 in CaCO3
(Fig. 14J) or the phosphate peak seen at 361 cm
21 in the
Ca3(PO4)2 control (Fig. 14K). As seen earlier during the FTIR
analysis, we also noticed that the Ca3(PO4)2 control contained
small impurities of carbonate that may have originated from
Figure 14. Micro-Raman spectroscopy of protein-mineral
nanoparticles shows chemical compositions similar to those
of calcium granules and NB. Protein-mineral nanoparticles were
prepared as in Fig. 9, by adding 0.3 mM each of CaCl2 and NaH2PO4 to
DMEM containing BSF (A), HSA (B), or both proteins (C), followed by
incubation in cell culture conditions for 1 month and processing for
micro-Raman spectroscopy. Calcium granules were obtained by adding
CaCl2 (D), NaH2PO4 (E), or both (F) to FBS, followed by overnight
incubation and preparation for micro-Raman spectroscopy as described
in the Materials and Methods. Micro-Raman spectra were also acquired
for NB that were initially cultured from 10% HS (G, ‘‘HS-NB’’) or 10% FBS
(H and I, ‘‘Nanons’’ and ‘‘DSM 5820’’, respectively). These nanoparticle
samples showed phosphate groups at 361 cm
21, 440 cm
21, 581 cm
21,
962 cm
21,1 , 0 0 2 c m
21 (HPO4
22), and 1,048 cm
21 and carbonate
moieties at 280 cm
21, 712 cm
21, 1,080 cm
21, and 1,150 cm
21. The
protein-mineral nanoparticles mainly showed peaks of phosphate and
lower peaks of carbonate (A–C) while the calcium granules (D–F) and
NB (G–I) samples showed carbonate and phosphate peaks of variable
intensities. The three controls CaCO3 (J), Ca3(PO4)2 (K), and HAP (L),
diluted and washed in double-distilled water, were included for
comparison.
doi:10.1371/journal.pone.0008058.g014
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carbonate peak seen at 1,080 cm
21). In the case of calcium
granules and NB specimens prepared from serum, these samples
also produced variable phosphate and carbonate signals depend-
ing on the serum lots used (Fig. 9D–I, see also ref. [3]). For
instance, calcium granules prepared in FBS, following the addition
of calcium, produced small peaks of HPO4
22 and carbonate that
were rarely seen in the controls (Fig. 14D, see refs. [136,137]
where the peaks found at 1,002 cm
21 and 1,150 cm
21 were
attributed respectively to HPO4
22 and carbonate). In addition, a
few NB specimens like ‘‘DSM 5820’’ did not produce any
noticeable signal (Fig. 14G).
In spite of a significant dampening of signals seen here and
together with the EDX and FTIR analyses, it can still be inferred
that the micro-Raman data show that the nanoparticles prepared
in supersaturated solutions containing BSF and/or HSA have a
chemical composition largely similar to that of both calcium
granules and NB.
To complete the chemical analysis of the protein-mineral
nanoparticles, we used powder X-ray diffraction (XRD) spectros-
copy to study the nature of the crystals found in these samples. For
the protein-nanoparticles obtained from supersaturated solutions
(BSF-NLP, HSA-NLP and BSF-HSA-NLP), no peak was obtained
from the XRD analysis (Fig. 15A–C), indicating a predominance
of amorphous phases here. Precipitation of calcium phosphate is
usually described to proceed from an amorphous precursor phase
which slowly transforms into various calcium phosphate com-
pounds of increased crystalline complexity, ending with the
crystalline apatite, which is the more thermodynamically stable
end-product [138]. This transition does in fact also occur with
protein-NLP, and, upon prolonged incubation or by using lower
protein-to-calcium-phosphate ratios, several protein-NLP samples
have been shown to progress to crystalline patterns, including the
display of classic Ca10 apatite signals (Fig. 15D–F). Thus, in the
case of these particles, the intensity of the peaks could be
modulated by the amount of calcium, phosphate, and proteins
added as well as the length of incubation. In general, the spectra
will shift more rapidly toward the crystalline phases in the presence
of higher amounts of precipitating ions, longer incubations, and
lower amounts of proteins. It is likely that the presence of proteins
in association with the mineral phase promotes the formation of an
amorphous mineral phase that either blocks or slows the transition
to apatite, a concept that has been advocated in the past by Mann
and other researchers [58].
In support of this notion, the calcium granules prepared in serum
in the presence of high concentrations of calcium and phosphate
ions also showed variable levels of crystallinity depending on the
amount of serum present as well as the amounts of calcium and
phosphate added (Fig. 15G–I). Of particular interest is the fact that
calcium granules prepared from FBS often displayed crystalline
peaks of Ca10 apatite, as indicated by the prominent peak at 31.8
degrees on the 2-h scale (Fig. 15G and H), comparable to that seen
with the commercially available HAP powder used for comparison
(Fig. 15O), while the calcium granules prepared in HS showed a
similar propensity to remain amorphous (Fig. 15I; see also ref. [3]
for similar data). This may be attributed to higher protein
concentrations associated with HS (averaging 60 mg/ml) compared
to FBS (32 mg/ml; see Materials and Methods). While the FTIR and
micro-Raman analyses suggest that carbonate should be present in
the mineral phase of the particles, the signal for carbonate was not
detected in our specimens (Fig. 15A–C and data not shown). This
result might be due to the absence of this particular diffraction
crystallineplaneinthesamplesexamined,oralternativelyduetothe
predominance of the HAP signal.
For comparison, it should be noted that the various NB
specimens tested also displayed variable amorphous and crystalline
patterns (Fig. 15J–L). For example, in one experiment, NB that
had been cultured from 10% HS showed complete conversion to
the Ca10 apatite compound under the conditions tested (Fig. 15J)
while other samples of ‘‘Nanons’’ and ‘‘DSM 5820’’ showed either
low peaks of calcium phosphate crystals (Ca5(PO4)3OH in
Fig. 15K) or only amorphous signals (Fig. 15L). The commercially
available controls of CaCO3,C a 3(PO4)2, and HAP that had been
incubated in DMEM were also included for comparison
(Fig. 14M–O).
The presence of both amorphous and crystalline patterns in all
the samples seen, including each of the protein-mineral complexes
examined, reveals the possibility of a continuous progression from
amorphous to crystalline dispositions that in turn can be
modulated by the types and amounts of proteins and minerals
present. In addition, both the presence of excess proteins (either
whole serum or purified proteins like fetuin-A or albumin) and
certain competing ions (magnesium or carbonate, data not shown;
see also ref. [2]) are now known to result in smaller particle sizes.
In fact, the XRD analysis of small mineral nanoparticles is often
complicated by the fact that only large crystals over a certain
dimension tend to diffract X-rays [139,140]. Thus, it is not entirely
clear whether the nanoparticles studied here are truly amorphous
during at least portions of their development or perhaps comprise
of small crystals that fail to diffract X-rays.
Conclusion and Future Perspectives
The results presented in this study further confirm a dual
inhibitory-seeding role for serum insofar as the formation of NB-
like calcifying particles is concerned, a notion that was first
advanced through our earlier studies [2,3] but that can now be
extended to encompass the effects of serum-associated proteina-
ceous factors and at least those of the two main serum proteins
albumin and fetuin-A. That is, calcification-inhibitory factors such
as albumin and fetuin-A are seemingly capable of combining with
calcium and phosphate to form amorphous nanoparticles, thereby
repressing them from progressing further onto crystalline phases
that appear in turn as spindles, aggregates, and biofilms. It is only
when these same inhibitors are overwhelmed by excess calcium
phosphate that mineral seeding will then occur. Since serum and
other body fluids are already supersaturated with respect to
calcium and phosphate, our results support fully the notion that it
is really the de-repression of this same predominantly inhibitory
state that results in the seeding of mineral crystals [52–58].
Our focus on serum and serum-derived factors as an
experimental platform to study the broader issue of nanoparticle
assembly can be seemingly justified by both the physiological
relevance of this system to biomineralization as well as the known
fact that serum has been used in the past as the body fluid of
choice for the culture of the putative NB [4,5,7–9]. These same
earlier studies had shown that when FBS and adult HS were
inoculated into DMEM at a final concentration of 10%, followed
by incubation in cell culture conditions for several weeks,
structures described as mineralized NB could be observed in most
samples in the form of a white precipitate adherent to the cell
culture flask [4,5,7–9]. Given that this precipitate was absent in
DMEM alone incubated in the same conditions, it was concluded
that the serum provided the source of putative NB [4,5,7–9]. Our
studies indicate that, in retrospect, the levels of serum used
(generally 10% and at times 5%) for the bulk of NB studies were
essentially and paradoxically inhibitory on NB formation. In our
own studies, as little as 0.1% serum triggered mineral precipitation
while the dose-dependent precipitation produced by serum
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achieved at 1–3% serum and with FBS generally giving peak
precipitations at lower concentrations as compared to HS. The
prominent inhibitory effect on mineral seeding shown by serum
can also explain now the slow time-course of mineral precipitation
associated with the entire NB phenomenology—generally taking
several weeks to months for noticeable precipitation to develop.
When these observations are factored in, it is now possible to view
NB from an entirely different perspective, as follows. In spite of the
fact that NB are lifeless mineralo-organic entities, they are
nonetheless real and verifiable, and they may in fact represent a
general mechanism of calcium homeostasis used throughout
nature [2,3].
It is with these perspectives in mind that we sought to dissect the
putative serum factor(s) that might account for the inhibitory-
seeding attributes associated with serum. It is not clear for example
Figure 15. Powder X-ray diffraction spectra of protein-mineral nanoparticles reveal both amorphous and crystalline patterns.
Protein-mineral nanoparticles were obtained as described in Fig. 9, by diluting the proteins, separately (A and B) or together (C) into DMEM, followed
by addition of the precipitating reagents CaCl2 and NaH2PO4 each to a final concentration of 0.3 mM and incubating the solutions in cell culture
conditions for 1 month. The XRD spectra obtained for the protein-mineral nanoparticles obtained after 1 week of incubation represented mainly
amorphous patterns as seen by the absence of diffraction peaks (A–C). Longer incubation of 1 month produced protein-mineral nanoparticles with
crystalline peaks corresponding to HAP crystals (D–F, Ca10(PO4)6(OH)2). XRD spectra were also obtained for calcium granules that were prepared by
adding either CaCl2 (G) or NaH2PO4 (H) into FBS or both CaCl2 and NaH2PO4 into HS (I), followed by sample preparation as described in the Materials
and Methods. Peaks corresponding to Ca10(PO4)6(OH)2 were obtained for both calcium granules prepared in FBS (G and H) while the ones prepared in
HS usually gave amorphous patterns (I). XRD spectra showing the presence of HAP crystals (J), a calcium phosphate compound (K, Ca5(PO4)3OH), or
an amorphous pattern (L) were also acquired for NB cultured in 10% HS for 1 month (J, ‘‘HS-NB’’) or in 10% FBS for 1 month (K, ‘‘Nanons’’) or 1 week
(L, ‘‘DSM 5820’’). Commercial grades of CaCO3 (M), Ca3(PO4)2 (N), and HAP (O), used as controls, were diluted and washed in double-distilled water.
doi:10.1371/journal.pone.0008058.g015
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serum represent the same exact entities. This latter question is all
the more relevant when one takes into account that, presumably, it
is the presence of prevailing inhibitory influences that keep
supersaturated solutions like serum from calcifying spontaneously
[52–58]. This is also to say that releasing such inhibitory
influences, as accomplished through protease or heat treatment,
may be sufficient to trigger calcification in supersaturated
solutions. According to Mann, whereas biomineralization can be
construed as a result of phase transformation from amorphous to
crystalline apatite phases, ‘‘‘promotion’ of various phases and
polymorphs does not occur in the literal sense, but that the
mineralization pathway is controlled through intermittent release
of a system under chemical repression’’ [58].
In fact, our studies point to a definitive role for proteinaceous
(e.g. protease and heat sensitive) factors in the inhibition of
calcification reactions associated with both bovine and human
serum. Indeed, once de-repressed from this same inhibition, be it
through protease or heat treatment of serum, it appears that this
same supersaturated solution, e.g. serum, will naturally nucleate
and precipitate minerals. Accordingly, this same chain reaction—
de-repression of inhibition, followed by calcification—can be enhanced
several fold by the addition of small amounts of calcium and
phosphate (0.3–1 mM).
In turn, the addition of these small amounts of precipitating ions
(calcium and phosphate) to metastable culture solutions like
DMEM has helped unravel attributes associated with protein-
linked calcification that are seemingly repressed or subdued in
metastable solutions. For instance, fetuin-A and/or albumin
inoculated into DMEM alone fail to produce any mineral
precipitation. On the other hand, mineral deposition is seen when
submillimolar amounts of calcium and phosphate are also added
concomitantly, and these ions can be effective even at the low ion
concentration levels that normally result in negligible or no
precipitation on their own. This synergistic interaction seen
between the proteins fetuin-A/albumin and precipitating ions,
resulting in apatite nucleation and deposition, further confirms the
propensity of these proteins to behave as calcification inhibitors. It
is only when the calcium-phosphate equilibrium is perturbed and
the apatite-binding capacities of these proteins are somehow
overwhelmed through calcium and phosphate loading that
mineralization is finally triggered.
The fact that the small amounts of precipitating ions added do
not result in any significant calcification on their own but that they
do in the presence of fetuin-A and/or albumin, suggests further
that the calcium or apatite-binding sites on these proteins may not
only bind to excess calcium or apatite, but that they may somehow
anchor and bridge the apatite chains so as to allow them to grow in
size, thereby forming in effect the nidi required for crystallization.
Thus, fetuin-A, itself a much stronger binder of apatite than
albumin ([74]; see also our apatite-binding calculations discussed
earlier), displays not only stronger inhibition of calcification as seen
in our experiments, but it clearly synergizes with precipitating ions
to produce calcification; however, this seeding effect is seen at
much lower protein-to-ion concentration ratios as compared with
albumin (Figs. 4–7). In other words, both seeding and inhibition of
NB-like particles appear to represent in fact two sides of the same
coin, with inhibition seen as the predominant state that
nonetheless gives in to seeding when it is somehow de-repressed.
In this sense also it would be reasonable to expect that a
stronger calcification inhibitor like fetuin-A, by it binding more
avidly to apatite, would be much more likely to be tightly
associated with nascent apatite nuclei as compared with other
more weakly apatite-binding proteins like albumin—a concept
that has been confirmed and extended through the elegant work
on primary and secondary CPPs done by Heiss and his co-workers
[73,74,94,141]. Our own morphological data indicate that the
fetuin-A-mediated mineral particles are more likely to look as
multi-walled sealed rings whereas albumin-particles are more
prone to resemble incomplete single-walled rings. Presumably,
fetuin-A, by it being a more avid apatite binder or inhibitor, is
more likely to cover an apatite nucleus entirely, thereby blocking
its access to further growth, whereas weaker inhibitors (albumin)
tend to produce an incomplete seal, which may facilitate the
further seeding and growth of apatite crystals. Nonetheless, the
results shown here and elsewhere [2,3,73,74,94,141] demonstrate
that any such inhibition, be it by a potent inhibitor like fetuin-A or
a weaker inhibitor like albumin, is only transient at best and, that,
eventually, there is a progressive and irreversible transformation of
the round particles to spindles and these to films and aggregates. In
full agreement with this notion and as shown by our own
spectroscopic and ultrastructural data, when fetuin-A and/or
albumin particles are fully developed, they end up becoming
virtually indistinguishable from the purported NB or calcium
granules grown out of whole serum and other more complex body
fluids.
Still in this respect, it should be noted that, to date, all NB-
related studies have been done in the presence of body fluids or
tissue homogenates inoculated into culture medium (reviewed in
refs. [2,43]). This procedure may very well have introduced small
amounts of calcium and phosphate, not to mention inorganic and
organic modulators with calcification-inhibitory-and-seeding prop-
erties, a situation that may be comparable to the conditions used
here with purified proteins, in which addition of exogenous
precipitating ions is also required for calcification to develop.
Proteins are present in high amounts in the serum and many of
them have been shown to bind to NB-like particles or granules
derived from the serum [2,3]. As far as biomineralization is
concerned, proteins are known to modulate the formation,
morphology, orientation, and growth of the apatite crystals found
in the mineralized tissues of living organisms (see the excellent
reviews on this topic in refs. [99,100,142]). Given their binding
affinities for calcium and apatite, certain proteins may interact
with the apatite crystals during the mineralization process and as
such they are expected to be enriched in mineralized tissues like
bones and teeth. Several questions however remain to be
addressed, including whether the same inhibitory-seeding role in
calcification seen here with serum and the serum proteins fetuin-A
and albumin has been documented elsewhere in the literature. It is
also not clear whether the seeding or inhibitory attributes
associated with a protein may not in fact be a function of the
protein’s conformational state, as we presumed to be the case
when attempting to unfold fetuin-A and albumin through heat and
immobilization treatments described in this study.
As it turns out, both inhibitory and seeding roles have been
ascribed to a number of mineralization-related proteins. Table 1
lists the many proteins implicated in mineralization in vertebrates
along with their tissue distribution and their (seeding and/or
inhibitory) effects on mineralization as seen both in vitro and in vivo.
To address further the role of a protein’s conformational state in
effecting either inhibition or seeding, we further segregated the in
vitro experiments referenced in Table 1 into proteins that had been
adsorbed onto solid substrates or dissolved in solution. Our
summary table confirms that, depending on the conditions used
for the studies, e.g. whether the proteins are adsorbed onto
substrates or are dissolved in solution, several proteins present in
the serum like albumin, fibrinogen, and vitronectin have actually
been shown to exhibit both seeding and inhibitory roles in vitro.
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same calcium and apatite binding proteins when adsorbed onto
solid substrates express nucleating or seeding tendencies while
their counterparts in solution tend to be inhibitory!
We have also noticed that these dual seeding-inhibitory
tendencies seen in vitro with some proteins may not in fact
correlate with their net mineralizing effect seen in vivo (Table 1). As
for the in vivo role of proteins presented in Table 1, a definitive
assignment could only be derived from the phenotype of mice that
were engineered to lack the gene coding for the protein in
question, as already done in the case of dentin matrix protein-1,
bone sialoprotein, fetuin-A, matrix gla protein, and osteopontin
(see the proteins marked with a single asterisk in Table 1 and the
corresponding references therein). However, in the absence of
gene knockout data, a potential role for some of the proteins was
proposed by the respective authors based on limited functional
studies and thus must be viewed with caution. Based on such
analyses, for example, albumin has been deemed to be a inhibitor
of mineralization in vivo [56,62], and yet this protein can display
either inhibitory or nucleating properties in vitro depending on the
conditions used (Table 1). As for fetuin-A, on the other hand, we
were not able to find any study documenting the effect of the
adsorbed protein; our own experiments reported here, however,
demonstrate that fetuin-A can also behave as a nucleator when
Table 1. Proteins associated with mineralization in vertebrates along with their tissue distribution, their effect on mineralization in
vitro, and their potential role in vivo.
Protein Tissue Distribution
Effect in vitro,
Adsorbed
a,b
Effect in vitro,
Dissolved
c
Possible
Role in vivo
d Ref.
Aggrecan (proteoglycan) Cartilage Inhibitor [143-145]
Albumin Blood, body fluids, bone Inhibitor/nucleator; no
effect
Inhibitor/nucleator Inhibitor This study [2,62–64,81–84,
102–112,146–149]
Amelogenin Enamel, bone, others No effect Inhibitor; no effect [109,150–153]
Biglycan (proteoglycan) Bone, connective tissues, teeth Inhibitor/nucleator Inhibitor [102,154–159]
Bone acidic glycoprotein-75 Bone, connective tissues, teeth Nucleator Nucleator [142,160,161]
Bone sialoprotein Bone, dentin Nucleator Inhibitor; no effect Nucleator* [142,162–170]
Chondrocalcin Cartilage, retina No effect No effect [165]
Collagen type I Bone, cartilage, dermis, others No effect Structure [99]
Decorin (proteoglycan) Bone, connective tissues, teeth Inhibitor/nucleator; no
effect
Inhibitor; no effect [102,154–159]
Dentin matrix protein-1 Bone, dentin, kidney, others Nucleator Nucleator* [142,148,171–174]
Dentin phosphophoryn Dentin Inhibitor/nucleator Inhibitor Nucleator [99,142,165,175–178]
Dentin sialoprotein Dentin Inhibitor/nucleator Nucleator [178,179]
Fetuin-A (a2-HS-glycoprotein) Blood, body fluids, bone No effect Inhibitor/nucleator Inhibitor* This study [2,56,57,66–
68,180,181]
Fibrinogen Blood Nucleator Inhibitor [104,110,182]
Fibronectin Blood, connective tissues Inhibitor/nucleator [106,107]
Lithostatin Pancreas, pancreatic secretion Inhibitor Inhibitor** [56,183–185]
Matrix gla protein Arteries, bone, cartilage Inhibitor* [56,186,187]
Osteocalcin (bone gla protein) Blood, bone, cartilage, teeth Nucleator; no effect Inhibitor [102,165,188–190]
Osteonectin Bone, dentin, others Inhibitor/nucleator; no
effect
Inhibitor [165,191–194]
Osteopontin Arteries, bone, kidney, others Inhibitor/no effect Inhibitor Inhibitor* [142,162,164,165,195,196]
Prothrombin fragment-1 Blood, urine Inhibitor Inhibitor*** [197]
Statherin Saliva Inhibitor Inhibitor [56,198–200]
Tamm-Horsfall protein Kidney, urine Inhibitor Inhibitor*** [201–203]
Uropontin Kidney, urine Inhibitor Inhibitor*** [56,204]
Vitronectin Blood, bone Inhibitor/nucleator [106]
aThe effect of the proteins on mineralization was studied in vitro following their adsorption onto solid substrates such as agarose beads, agarose gels, or collagen fibrils.
bThe term ‘‘Nucleator’’ refers to a protein which is able to induce mineral formation in a metastable solution where precipitation does not occur spontaneously. An
‘‘Inhibitor’’ consists of a protein which has the ability to delay or prevent mineral formation.
cThe effect of various proteins on mineralization was also studied following dissolution of each protein into a liquid buffer.
dThe word ‘‘Structure’’ refers to a protein which does not appear to induce or inhibit mineral formation by itself, but which is known to be important for the disposition
and the arrangement of minerals formed in vivo.
*The potential role of each protein during mineralization in vivo was proposed based on gene deletion studies in laboratory animals when available; in this case, the
proteins were denoted with a single asterisk. A role for the other proteins shown was proposed based on limited functional studies giving sometimes divergent results;
the role of these proteins should therefore be considered with strong reservation.
**Inhibition of pancreatic stones of calcium carbonate.
***Inhibition of kidney stones of calcium oxalate or calcium phosphate.
This Table was adapted and modified from the review by Benesch et al. [100].
doi:10.1371/journal.pone.0008058.t001
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with submillimolar amounts of calcium and phosphate.
Surprisingly, few studies to date have addressed the possibility of
fetuin-A representing a nucleator of calcium phosphate minerals.
In a recent report [141], the early stage of CPP formation was
studied based on a dynamic small-angle X-ray scattering analysis.
It was observed that fetuin-A at various concentrations (1, 5, or
15 mM) added to 20 mM calcium and 12 mM phosphate ions did
not in fact act as a nucleating agent of CPPs, but it essentially
inhibited their formation by ‘‘shielding’’ nascent mineral nuclei
[141]. Given that relatively high concentrations of calcium and
phosphate ions were used in these experiments, it is not clear
whether they are in fact representative of the slow and
spontaneous formation of NB grown in metastable solutions or
of NLP assembled in metastable solutions that had been
challenged with submillimolar amounts of precipitating ions, both
of which were meticulously addressed here. Other studies have
reported that by fetuin-A was effective only in delaying mineral
formation temporarily [71,205]. For instance, when fetuin-A was
present at 5 mg/ml in solutions containing 4 mM of calcium and
phosphate, precipitation in the form of a fetuin-A-mineral
complex appeared only after 4 to 5 days of incubation at room
temperature [71,205]. When calcium and phosphate ions were
present at 5 mM in these same conditions, the incubation time was
shortened to 20 to 24 hours [71,205]. These latter observations
clearly support our hypothesis of a dual inhibitory-seeding role for
fetuin-A.
The dichotomy seen between inhibitory and seeding tendencies
as a function of protein solubility (conformational state) is not in
fact limited to serum proteins. Thus, Table 1 illustrates that several
proteins associated with bones or teeth have also been found to
possess a dual seeding and inhibitory role on mineralization,
including biglycan, bone sialoprotein, decorin, dentin phospho-
phoryn, osteocalcin, and osteonectin. These proteins also show
marked propensity to act as apatite crystal nucleators when
adsorbed in vitro, consistent with the assumption that, once bound
to collagen fibrils, they may unfold and help nucleate the first
crystals required for collagen mineralization in vivo [99,100]. Given
the variabilities in seeding versus inhibition seen with the same
proteins under different conformational states, it would appear
that designating a protein as inhibitor or nucleator can be rather
arbitrary. We contend that, in principle, any proteinaceous
inhibitor of mineralization can be induced to nucleate under
conditions that result in a conformational change in its structure.
With regards then to the differences seen between adsorbed and
soluble proteins and still in the context of Table 1, it would appear
that apatite-binding proteins tend to act as nucleators of
calcification while the same proteins free in solution tend to act
as inhibitors, a notion that has also been advanced in several
earlier studies [97–100]. Presumably, an adsorbed protein may
provide binding sites that recruit and bridge ions so as to position
them in a specific tridimensional configuration needed to form a
mineral nucleus [101]. On the other hand, when free in solution,
the protein may still bind to precipitating ions, but it somehow
may either prevent them from forming a mineral nucleus or coat
the nascent crystal, thereby blocking any growing sites and
preventing further growth [99,101].
For our own experiments, we also attempted to immobilize
albumin and fetuin-A onto various substrates and monitored their
calcification effects in metastable solutions. Despite repeated trials,
we were unable to directly seed mineral nanoparticles under the
conditions used. While two earlier studies had reported that
albumin could promote the formation and growth of apatite
crystals when adsorbed to collagen [81,82] or to apatite itself,
using ceramics comprising of commercial apatite and calcium
phosphate [83,84], it is not clear how these results relate to our
own observations given the differences in experimental conditions
used. For one, the nature of the substrate used here could have
played a role in the absence of effect observed. It is also not clear
how the effect of albumin can be ascertained from its
immobilization onto apatite or calcium phosphate crystals, which
are known to promote the nucleation of other identical crystals by
secondary nucleation [118]. In addition, the concentrations of
calcium and phosphate used could also have played a role in the
different responses obtained. Additional experiments are needed to
reconcile these differences.
It should also be noted that although we did not obtain
calcification in a metastable medium (DMEM) using either
immobilized fetuin-A or immobilized albumin, we were however
able to demonstrate seeding with heat-treated albumin (Fig. 7).
Heat-treated fetuin-A, on the other hand, failed to seed under the
same conditions. The only seeding seen with fetuin-A (also seen
with albumin) was in the presence of submillimolar amounts of
calcium and phosphate added simultaneously to DMEM. This
property may be attributed to the potent inhibitory effect on
apatite formation associated with fetuin-A. Albumin, by compar-
ison, being a much less effective inhibitor of apatite nucleation
[74,94], has shown a greater tendency to mineralize under the
conditions studied.
Viewed from a different perspective, the differential display of
inhibitory versus seeding tendencies may depend on the
stoichiometric relationship between the number of protein
molecules versus the number of precipitating ions available in
any given environment. Thus, our results indicate that, for any
calcium or apatite binding protein and for given amounts of
calcium and phosphate present in a medium, the protein
concentration should certainly influence its effect on mineraliza-
tion. This relationship can be illustrated by the significant
differences seen with the amounts of fetuin-A versus albumin
needed to trigger calcification (Figs. 4–7). That is, fetuin-A is such
an effective binder of apatite that it will seed apatite minerals not
only when the protein-to-mineral ratios are low compared to that
seen with albumin but also only with the concomitant addition of
submillimolar amounts of calcium and phosphate. Based on these
considerations, and extrapolating further to body conditions,
fetuin-A should behave as a potent inhibitor of calcification at
levels found in the body fluids, while it will nucleate at low protein
concentrations only in the presence of excess calcium and
phosphate. This is not surprising since according to our
calculations, each bovine fetuin-A molecule binds to 54–58 apatite
units while each human albumin molecule binds to 4 apatite units.
In fact, due to these same stoichiometric considerations, low
concentrations of calcium or apatite binding proteins have been
generally associated with nucleation of mineral formation whereas
high concentrations are known to usually delay or inhibit this same
process [100]. In fact, according to Boskey, any macromolecule
that can bind and coat nascent crystals will inhibit crystal growth
when present in high concentrations in solution [206].
Proteins that inhibit mineral formation are thought to play an
important role by preventing spontaneous calcification of the
serum and the extracellular fluids [52,54,56]. This role is critical
given the high natural propensity of these supersaturated
extracellular fluids in vertebrates to calcify [52–58]. Direct
evidence for the role of these proteins in preventing calcification
in vivo comes from the observations that mice designed to lack any
one of the calcification inhibitors like fetuin-A, matrix gla protein,
or osteopontin are prone to ectopic calcification and to the
debilitating effects associated with this process [67,68,186,196].
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as inhibitors of mineralization, several proteins listed in Table 1
have been shown to be able to initiate mineral formation as well.
Proteins like bone sialoprotein, biglycan, and decorin interact with
the collagen fibrils and are thought to initiate the formation of the
first mineral nucleus required for collagen mineralization [99,142].
Collagen fibrils are often described to play a structural role by
forming a receptacle which can delineate the main area destined to
become mineralized in bones [99,100]. Proteins can initiate
mineralization by lowering the activation energy required for the
formation of the first mineral nucleus in metastable solutions
which usually does not occur spontaneously [101]. Given that the
extracellular fluids are saturated in calcium and phosphate ions
[52–58], the formation of mineral nuclei is thought to be sufficient
to initiate mineralization, which in turn can proceed further on its
own by the deposition of calcium and phosphate ions onto the
nascent nuclei. It is further assumed that an effective mineral
nucleator should provide an array of functional groups, particu-
larly carbonate groups as well as phosphorylated residues, which
possess high affinity for calcium and phosphate ions [101,142].
Accordingly, several studies have suggested that proteins present in
the serum may also act as nucleators of calcification. Strong
evidence for the presence of a putative nucleator(s) in the serum
comes from the observation that demineralized bones incubated in
DMEM containing as low as 1.5% serum can remineralize
following incubation for a few days [207–209]. This remineral-
ization did not proceed if the demineralized bones were incubated
in DMEM alone for the same period of time [207–209]. The
factor responsible for this remineralization, which remains
unidentified, was attributed to one or more protein(s) with a
molecular weight between 55–150 kDa [207,209] and which
required dephosphorylation by alkaline phosphatase to become
activated [210]. At first sight, this suggestion might appear
paradoxical given that various systems including proteins are
present in the serum to prevent calcification at any given time.
Nevertheless, the observation that blood is continually in contact
with bones through the so-called basic multicellular unit and bone-
remodeling compartment—two anatomical structures that are
associated with remodeling of cortical and cancellous bones,
respectively [211,212]—leads to the possibility that a protein
secreted by osteoblasts to initiate mineralization in bones might
end up circulating in the blood at low concentrations [208,209].
Were this scenario to occur in vivo, it is likely that spontaneous
calcification of blood would be prevented as long as the other
major inhibitory systems remain in place [208,209]. Whether or
not this putative nucleator(s) plays a role in the formation of NB in
cell culture conditions is still unclear.
Still with regards to fetuin-A and albumin, it should be noted
that we selected these two proteins for our demonstration of a dual
inhibitory-seeding model for protein-mediated mineralization
since they represent the two main proteins found in association
with NB-like particles [1–3,46]. Their effect on mineral formation
has been studied extensively in the past mainly because they are
present in high amounts in mineralized tissues. These findings
have long suggested that the two proteins might play a role in the
mineralization process [56,57,81,82]. Alternatively, the binding of
these two proteins to the mineral phase of bones may simply reflect
their high affinity for both calcium phosphate and apatite [94]. In
support of this alternative view and as noted earlier, proteins from
blood are in constant contact with bones and this could account
for the gradual enrichment of albumin and fetuin-A in mineralized
tissues. Both albumin and fetuin-A are also found at high
concentrations in the serum used to culture NB. In fact, albumin
represents the main protein found in both the fetal bovine and
adult human sera while fetuin-A is more abundant in FBS than in
HS [92–96]. Both proteins can inhibit or delay the precipitation of
calcium phosphate in vitro [2,3,62–64,66,110,111] and both bovine
fetuin-A and human albumin have been shown to account for a
significant portion of the calcification-inhibitory effect associated
with each serum [62,66]. In fact, earlier studies made on the
inhibitory capacity of human serum showed that two-thirds of the
inhibitory potential of the serum studied was due to proteins and
other macromolecules of high molecular weights while the other
one-third of the inhibitory capacity could be attributed to
compounds of low molecular weights [62]. Further observations
made on albumin-depleted serum indicated that albumin
accounted for about half of the inhibitory effect of the high
molecular weight fraction present in the serum [62].
Similarly, when fetuin-A-depleted FBS was incubated in
DMEM in cell culture conditions, it was reported that a precipitate
of calcium phosphate would form in the bottom of the flask within
6 days of incubation [205]. It thus appeared that the removal of
fetuin-A was sufficient to induce mineral precipitation from
DMEM under these conditions. Given that the DMEM used in
this study was also supplemented with phosphate to a final
concentration of 2 mM [205], further experiments are needed to
evaluate whether these observations are relevant to our own
findings with NB and protein-minerals described here. While more
experiments are required to integrate and compare the various
systems of calcification used here and elsewhere, together, these
results strongly support the notion that both fetuin-A and albumin
represent major repressors of spontaneous calcification associated
with the serum.
The calcification-inhibitory effects associated with fetuin-A and
albumin can be attributed to the presence of several calcium and
apatite binding sites on these proteins which may presumably
sequester calcium and phosphate ions before they bind to the
growing crystals [2,3,62–64,66,110,111]. In addition, the calcium
or apatite binding sites may tentatively mediate inhibition by
binding onto the growing sites of the nascent crystals and blocking
further mineralization. Albumin has been shown to possess as
much as thirty calcium-binding sites with three different binding
affinities [60] while fetuin-A has been shown to have six calcium-
binding sites per molecule with two different binding affinities
[65]. The calcium-binding constants associated with the fetuin-A
molecule are generally lower than the ones obtained for albumin,
an observation which suggests that the binding sites of fetuin-A
have a higher affinity for calcium than those of albumin [65]. In
addition to the potential influence of calcium-binding sites, the
inhibitory effect of these proteins on mineral formation can also be
attributed to the presence of specific protein motifs which promote
the interaction of the proteins with growing crystals. Indeed,
fetuin-A possesses a motif consisting of a cystatin-like domain with
several basic amino acids which has been shown to interact with
calcium phosphate and apatite crystals [66,94]. The removal of
this motif on fetuin-A by mutational analysis showed that it was
responsible for the relatively strong inhibition effect of this protein
[66,94]. While no specific mineral-binding motif has been
described for albumin, the interaction of this protein with apatite
crystals has been attributed instead to the multiple calcium-
binding sites present on this protein [62-64]. The possibility that a
protein conformation might be associated with the inhibitory effect
of albumin was also suggested by the observation that heat-
denatured albumin showed increased inhibitory effect compared
to the native protein [62], a result that we could not confirm
however through our own experiments. Given that these two
proteins are present in relatively high amounts in the serum, it is
possible that they would play a predominant role in the inhibition
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in the body. Taken together, these earlier studies suggest that the
high inhibitory effect of albumin may be attributed mainly to its
relatively high concentration in the serum [62,74] while the
stronger inhibitory effect of fetuin-A may be attributed in turn to
its strong interaction with apatite crystals [74,94].
In the context of biomineralization, perhaps no other protein
has given more divergent and even contradictory results in terms
of seeding or inhibition than albumin. These discrepancies were
more noticeable when studies were done via adsorption of albumin
to various solid substrates of well-defined chemical composition.
For instance, albumin had earlier been shown to promote the
nucleation of calcium phosphate crystals when adsorbed onto a
substrate, but to essentially act as an inhibitor of mineral
deposition when dissolved in solution [83]. In these experiments,
albumin was adsorbed onto ceramics of apatite and calcium
phosphate and immersed into a buffer containing high concen-
trations of calcium and phosphate similar to those contained in the
serum [83,84]. Precipitation of calcium phosphate, verified by
SEM and FTIR, was found to be more prominent when albumin
was adsorbed on the surface [83,84]. However, other authors have
reported that albumin seemed to exert an inhibitory effect or a
lack of nucleating effect irrespective of its being adsorbed to
titanium or agarose beads or its being dissolved in solution
[102,105]. The discrepancy seen between these observations has
been attributed to the nature of the substrates which may
seemingly have produced different protein conformations
[83,84,149]. As such, the presence of a specific albumin
conformation which allows for both firm adsorption to a surface
and binding of calcium from the solution is thought to be required
for albumin to induce mineralization [83,149]. In another set of
experiments, the presence of albumin in solution has also been
described to promote the mineralization of phosphate ceramics
[84]. In this case, the presence of a carbonate-buffered solution
was found to alter the charge characteristics of albumin and to
increase mineralization of phosphate ceramics when compared to
solutions where no albumin or carbonate buffer was used [84]. In
yet another study, the dual inhibitor-nucleator effect of albumin
described here could also be seen in the context of collagen type I-
mediated mineralization and was shown to depend on the
concentration of albumin used [81]. When albumin was present
at low concentrations (below 10 mg/ml) in supersaturated
solutions containing 3.6 mM of calcium and 2.7 mM of phosphate
ions, it appeared to exert a nucleating effect on collagen
mineralization and to lead to increased crystal growth whereas
high concentrations (above 10 mg/ml) essentially inhibited
mineral formation [81]. Albumin also had an effect on the
induction time needed for mineralization to start, extending the
period of time for mineral to appear when compared to solutions
where albumin was absent [81]. Accordingly, the disparate results
may be attributed to several factors which can include the nature
of the mineralization assay used, the provenance, purity, and
characteristics of the protein used, as well as the different criteria
used to describe its mineralizing function [82,100].
Together, these studies illustrate the complexities as well as the
subtleties seen in terms of seeding and inhibition functions that can
be attributed to a single protein, all of which may depend on both
the conformational changes as well as the concentrations of the
same protein found in any given compartment. These inherent
attributes of calcification-related proteins make it difficult if not
altogether impossible to classify the respective roles of the same
proteins during the mineralization process without first consider-
ing their physiological context (see also the excellent reviews in
refs. [82,100]).
Since we were not able to produce NB-like minerals using only
fetuin-A and/or albumin inoculated into a metastable medium like
DMEM, without first heat-inactivating these proteins and adding
exogenous calcium and phosphate, it is possible that other serum
factors may be involved in the formation of the NB-like particles
seen here and in the earlier studies. Lipids had earlier been shown
to be associated with NB-like particles derived from the serum (ref.
[2] and unpublished observations). Preliminary experiments show
that, in addition to proteinaceous factor(s), lipids in the form of
membrane or matrix vesicles (MV) may actually be involved. MV
are small lipid-bound vesicles released by the vast majority of cells,
but in the context of collagen-independent mineralization, they are
especially significant in that they are known to be actively released
by skeletal cells like osteoblasts, chondrotonblasts, and odonto-
blasts, and are in turn capable of nucleating the deposition of
calcium phosphate in specific areas of the body (see the
comprehensive review by Anderson et al. [213]). The release of
these vesicles is associated with the mineralization of bones,
cartilage, and teeth [213]. In bones, the release of MV is thought
to be associated with mineralization away from collagen fibrils in
the endochondral plaque [214]. Ectopic calcifications are thought
to be associated with the release of MV-like vesicles by vascular
smooth muscle cells which experience insults of high concentration
of phosphate ions [215,216]. The mechanism of mineral
deposition by matrix vesicles is thought to involve the presence
of calcium and phosphate channels in the membrane delineating
MV; these channels gradually increase the concentration of
calcium and phosphate ions within MV until mineral precipitation
ensues [213]. In the context of NB formation, while our earlier
studies have failed to provide conclusive evidence for a role of
lipids in this process [2], we are now able to extract lipids, in the
form of MV, directly from serum samples and use them to seed
NLP in vitro (data not shown). These same membrane vesicles have
earlier been shown to be found in the blood and in most if not all
body compartments [213,217]. In this context, it should be noted
that the earlier study by Cisar et al. [44] had in fact shown that
lipids like phosphatidylinositol are indeed capable of seeding
apatite particles that are morphologically similar to the putative
NB, thereby providing a direct link between lipid moieties and the
seeding of apatite nanoparticles in a metastable medium like
DMEM.
A yet another recently proposed mechanism of mineralization
that needs to be considered in the context of NLP formation
involves the hydrolysis of polyphosphate present in dense calcium
phosphate granules seen in tissues experiencing mineralization
[218]. Presumably, this hydrolysis can be catalyzed by alkaline
phosphatase [218].
Finally, it is not clear whether the protein-mineral nanoparticles
and NLP described here are related in any way to the so-called
proteons and proteon-nucleation centers (PNCs) previously shown
to represent blood-derived, metallic nanoclusters associated with
serum protein fragments such as hemoglobin alpha-chain [219]. It
is also not clear whether the more recently described proteon-
associated, cell-like nanoforms in the blood that can be produced
by hypotonic hemolysis are in any way related to the nanoparticles
or their underlying assembly mechanisms described here [220].
Mineralization inside the body is thought to occur through the
formation of an amorphous phase of calcium phosphate which
gradually converts into the more stable apatite ([221]; see also ref.
[116] addressing current controversies surrounding this topic).
Our own data indicate that much of this amorphous-crystalline
phase transformation can be mimicked through in vitro studies of
the kind reported here. Our studies indicate that the protein-
mineral particles assembled using fetuin-A or albumin are in many
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NB and calcium granules. Our results point to an orderly and
successive morphological conversion from spherical nanoparticles
to spindles, and these to films, that are comparable despite the
diverse environments in which these same particles and aggregates
are found. The binding of proteins and possibly other organic
compounds to nascent apatite is what apparently sustains the
particles in their spherical conformations, while the growth of
apatite crystals will eventually de-repress this same inhibitory
influence resulting in the fusion of the round nanoparticles
allowing them to coalesce to form spindle and film-like shapes.
Whether this general progression of morphologies is restricted to
calcium phosphate or may be conceptually extended to other
minerals in general remains to be explored.
Materials and Methods
Culture of NB from Serum
NB specimens were cultured from FBS or HS as described
before [5,85]. Approval for the use of human samples in this study
was obtained from the Institutional Review Board of Chang Gung
Memorial Hospital (Gueishan, Taiwan, Republic of China).
Written informed consents were signed by the individuals who
provided blood samples. Human blood was obtained from healthy
volunteers by venipuncture following sterilization of the skin with
alcohol. The blood was withdrawn into sterile Vacutainer tubes
containing no anticoagulant (Becton, Dickinson & Company,
Sparks, MD, USA). Whole blood was centrifuged at 1,5006g for
a period of 15 min at room temperature. The supernatant
corresponding to HS was retrieved and placed into another tube.
The FBS (Biological Industries, Kibbutz Beit Haemek, Israel; PAA
Laboratories, Pashing, Austria) and HS used throughout this study
were sterilized by filtration through both 0.2-mm and 0.1-mm
membranes (Pall Corp., Ann Arbor, MI, USA) prior to use. To
culture NB, both sera were diluted into DMEM (Gibco, Carlsbad,
CA, USA) to final concentrations ranging from 0.1% to 10%.
Culture was performed in 24-well plates with flat-bottom wells and
covering lid (Corning, Inc., Corning, NY, USA) using a final
volume of 1 ml per well. Culture was also performed in 75-cm
2
flasks with 0.2-mm vented caps (Corning) using a final volume of
20 ml per flask. Untreated DMEM was used as a negative control.
The culture plates and flasks were incubated at 37uC for several
months in the humidified atmosphere of a cell culture incubator.
Nanobacterium sp. strain DSM 5820 was obtained from the German
Collection of Microorganisms and Cell Cultures (DSMZ;
Braunschweig, Germany). Culture of ‘‘nanons’’, which was
initially called ‘‘Nanobacterium sp. strain Seralab 901045’’ [46,86],
was kindly provided by Dr. Didier Raoult (Unite ´ des Rickettsies,
Centre National de la Recherche Scientifique UMR 6020, Faculte ´
de Me ´decine, Marseille, France). Both NB strains DSM 5820 and
‘‘nanons’’ were originally isolated from commercially available
FBS used for cell culture purposes [86].
To prepare NB samples for electron microscopy and spectros-
copy analyses, the cell culture medium of a flask containing a 1-
month-old culture of NB was discarded and the NB sample which
consisted of a white precipitate adherent to the flask was scraped
using a sterile cell scraper (Corning). The precipitate was
resuspended in 1 ml of DMEM and centrifuged at 16,0006 g
for 15 min at room temperature. The pellet was washed twice with
DMEM, HEPES buffer (20 mM HEPES, 1 mM CaCl2,2m M
Na2HPO4, 0.02% sodium azide, and 0.15 M NaCl, pH 7.4), or
double-distilled water using the same centrifugation steps. The NB
specimen was resuspended in a small volume of double-distilled
water and used for the microscopy and spectroscopy analyses.
Photography and Spectrophotometry
Images of the 24-well plates used throughout this study were
obtained using a scanner operating in the reflective light mode
(Scan Maker 8700, MicroTek, Hsinchu, Taiwan) as described
earlier [2]. Spectrophotometry readings of 24-well plates were
performed at 650 nm using a Spectra Max M2 spectrophotometer
(Molecular Devices, Sunnyvale, CA, USA), essentially as described
[2]. Throughout this study, photographic and A650 turbidity
readings referred to as ‘‘Day 1’’ were taken within one hour
following the preparation of each 24-well plate.
Culture of NB-Like Particles from Protease-Treated Serum
and Boiled Serum
Stock solutions of porcine pancreas trypsin (Sigma, St-Louis,
MO, USA) or bovine pancreas chymotrypsin (Sigma) were
prepared in water at a concentration of 5% (w/v). The protease
solutions were sterilized by filtration through a 0.2-mm membrane.
The NB-like particles depicted in Fig. 2 were prepared by adding
trypsin or chymotrypsin into FBS or HS at a final concentration of
0.5% (v/v), followed by incubation at 37uC for 2 hours. A final
volume of 1 ml of serum was used. Following incubation, the
solution was diluted to final concentrations ranging from 0.1% to
10% (v/v) in DMEM and the mixture was incubated in cell
culture conditions for several weeks. Alternatively, this experiment
was repeated by treating FBS or HS with trypsin or chymotrypsin
that had been boiled at 95uC for 1 hour. As a negative control,
the stock solutions of trypsin or chymotrypsin were diluted
into DMEM to final concentrations ranging from 0.01% to 3%
(v/v) prior to incubation. The DMEM used for these experi-
ments contained 0.02–0.2% sodium azide in order to prevent
contamination.
To culture NB-like particles from boiled serum as shown in
Fig. 3, HS was first diluted to 25% (v/v) using double-distilled
water. FBS and 25% HS solutions were boiled at 95uC for 10, 30,
or 120 min. The boiled sera were then diluted into DMEM to
final concentrations ranging from 0.1% to 10% (v/v) and the
solutions were incubated in cell culture conditions for several
weeks. In some instances, stock solutions of 0.25 M CaCl2 and
NaH2PO4 (both at pH 7.4) were successively added at a final
concentration of 1 mM prior to incubation. The pH of the stock
solution of 0.25 M CaCl2 was adjusted to 7.4 with 1 M HCl or
1 M NaOH whereas the pH of the NaH2PO4 solution was
adjusted to 7.4 with 0.25 M Na2HPO4. These solutions were also
sterilized by filtration through a 0.2-mm membrane prior to use.
Parallel experiments were also conducted by adding aliquots from
0.25 M NaHCO3 pre-adjusted to pH 7.4, to the same final
concentrations as those of CaCl2 and Na2HPO4. Results were
virtually identical compared to experiments without carbonate.
For brevity, only the data for the addition of calcium and
phosphate are shown in the present study.
Seeding of NB-Like Particles by Fetuin-A, Albumin, and
Serum in Supersaturated Solutions
Stock protein solutions of BSF and HSA were prepared by
dissolving the protein in HEPES buffer at a concentration of
10 mg/ml, followed by filtration through 0.2-mm filters. Several
lots of proteins were used for the experiments described in this
study. For Fig. 4, BSF and HSA were obtained from AppliChem
(Boca Raton, FL, USA); for Fig. 5, BSF and HSA were from
Sigma; and for Fig. 6, BSF was from Sigma while HSA consisted
of a sterile solution used for intravenous injections (PlasbuminH-25;
Talecris Biotherapeutics, Inc., Research Triangle Park, NC, USA).
The stock solutions of proteins were then diluted into DMEM,
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0.7 mg/ml and 40 mg/ml. Other cell culture media obtained from
Gibco were used in parallel, including Roswell Park Memorial
Institute 1640 or RPMI-1640, F12 medium, medium 199,
Glascow minimum essential medium, and Leibovitz L-15
medium. In some experiments, the precipitating reagents CaCl2
and NaH2PO4 were added to final concentrations varying
between 0.1 mM to 1 mM. The final solution volume used was
1 ml. The solutions were then incubated in cell culture conditions
for several weeks. The concomitant addition of carbonate, as
outlined in the previous section, yielded similar results and data for
such experimens are not shown here.
To culture NB-like particles from boiled protein solutions as shown
in Fig. 7, solutions of BSF purified from FBS (Sigma) or BSA purified
from FBS (Sigma) were prepared in HEPES buffer at a final
concentration of 25 mg/ml. The protein solutions were filtrated
through 0.2-mm membranes prior to use. These protein solutions were
boiled at 95uC for 10, 30, or 120 min. The boiled protein solutions
were diluted in DMEM at final concentrations ranging from 0.02 mg/
ml to 2 mg/ml for boiled BSF and from 0.04 mg/ml to 4 mg/ml for
boiled HSA. In some experiments, the precipitating reagents CaCl2
and NaH2PO4were added successively each at a final concentration of
1 mM to the DMEM solutions containing proteins. The solutions were
incubated in cell culture conditions for several weeks.
In order to evaluate the possibility that adsorbed proteins nucleate
NB-like particles, BSF (Sigma), BSA (Sigma), or HSA (Talecris) were
used in adsorption experiments. Adsorption of the proteins to
polystyrene 24-well plates was performed by covering each well with
250 ml of protein solution at concentrations varying between 20 mg/ml
to 10 mg/ml. Similarly, 250 ml of FBS and HS were also used at
concentrations varying from 0.1% to 10%. The plate was incubated at
4uC overnight. Following incubation, the protein solution was removed
and each well was washed twice with 250 mlo fD M E M .W ev e r i f i e d
that the proteins used were adsorbed to the plate by staining the wells
with 250 ml of Coomassie blue diluted 1:5 in double-distilled water
(Dye reagent concentrate; Bio-Rad Laboratories, Hercules, CA, USA).
After 10 min of incubation, the shift to blue color was monitored
directly by visualization of the plate and compared to controls without
proteins which did not produce the blue color. Following adsorption of
the proteins, 1 ml of DMEM was deposited in each well and the plate
was incubated in cell culture conditions for several months.
Alternatively, the protein solutions were deposited in each well and
left to dry overnight under a laminar flow hood. Each well was washed
twice with DMEM. 1 ml of DMEM was pipetted into each well and
the plate was incubated in cell culture conditions. The coating agents
poly-lysine (Sigma) and octadecyltrichlorosilane (OTS; Sigma) were
also used to promote adherence of the proteins to the bottom of each
well. For coating with poly-lysine, 250 ml of a 0.5% (w/v) solution of
poly-lysine was incubated into each well. The plate was incubated for
5 min and the solution was removed. The plate was then incubated
with the protein solution at 4uC overnight or left to dry overnight,
followed by the same procedure described above. For coating with
OTS, 250 ml of a solution of 0.5% (w/v) OTS was pipetted into each
well and dried for 5 min. The protein solutions were then deposited
into each well and the plate was processed as described above.
Precipitation was monitored regularly by A650 turbidity readings, by
visual inspection, and by using a cell culture inverted microscope
(Diaphot; Nikon, Tokyo, Japan) at a magnification of 400X.
Estimation of the Number of Apatite Crystals Bound to
Each Fetuin-A or Albumin Molecule under Conditions
that Produce Optimal Turbidity of Seeded Nanoparticles
The number of apatite crystals bound to each molecule of BSF
or HSA was calculated for the experiment described in Fig. 6,
under conditions that produced maximal precipitation of seeded
nanoparticles following one month of incubation. For instance,
when 0.7 mM of precipitating reagents was added to the three
different protein solutions, followed by incubation for one month,
maximal turbidity was observed at 21 mg/ml for BSF and at
0.4 mg/ml for HSA. An example of the calculation performed is
described here for 0.7 mM of precipitating reagents added to
DMEM in the presence of BSF at a concentration of 21 mg/ml.
We estimated the number of apatite crystals bound to each protein
molecule for these conditions by dividing the number of phosphate
ions by the number of protein molecules present in the well. Since
the molar concentration of phosphate ions present in the well was
lower than that of calcium ions, we considered that phosphate
would be the limiting factor for the formation of apatite crystals
under these conditions. To calculate the number of phosphate ions
present in the well, we added the concentration of phosphate ions
used (0.7 mM) to the concentration of phosphate already present
in DMEM (0.9 mM). This number was then converted to the
number of moles of phosphate present in the well which contained
1 ml of solution (1.6610
26 moles/well). This value was multiplied
by Avogadro’s number (6.023610
23 atoms/mole) in order to
obtain the number of phosphate ions present in the well
(9.64610
17). We assumed that all the phosphate ions present in
the well would form apatite crystals after prolonged incubation.
Thus, the number of phosphate ions present in the well
(9.64610
17) was divided by the number of phosphate ions present
in a single crystal unit of apatite (this latter value was averaged to
63 phosphate ions based on earlier estimations, see ref. 94). The
estimated number of apatite crystals (1.53610
16) was then divided
by the number of BSF molecules present in the well at a
concentration of 21 mg/ml (2.64610
14 molecules of BSF) in order
to obtain the number of apatite crystals bound to each molecule of
BSF (58 apatite units/BSF molecule).
Sodium Dodecyl Sulfate Polyacrylamide Gel
Electrophoresis (SDS-PAGE)
NB-like particles containing fetuin-A and/or albumin like the
ones shown in Fig. 8 were prepared by diluting BSF (Sigma) at a
final concentration of 20–160 mg/ml in DMEM or HSA (Talecris)
at a final concentration of 0.2–1.6 mg/ml in DMEM. The
precipitating reagents CaCl2 and NaH2PO4 were then added each
at a final concentration of 3 mM. A final volume of 1 ml of
DMEM was used. Incubation was done in cell culture conditions
for 1 month. The particles were then pelleted by centrifugation at
16,0006 g for 15 min at room temperature. The pellet was
washed twice with HEPES buffer using the same centrifugation
steps. The particles were resuspended in 50 ml of 50 mM EDTA.
Each sample was mixed with the 5X ‘‘loading buffer’’ (0.313 M
Tris-HCl pH 6.8, 10% SDS, 0.05% bromophenol blue, 50%
glycerol, 12.5% b-mercaptoethanol) to obtain a final concentra-
tion of ‘‘loading buffer’’ of 1X in a volume of 20 ml. 50 mM
EDTA was used to dilute the samples. The protein solutions were
heated at 95uC for 5 min and were subsequently loaded on a 10%
SDS-polyacrylamide gel. For Fig. 8A, BSF-NLP were prepared by
using DMEM (final volume of 1 ml) containing BSF (Sigma) at
20 mg/ml (lane 1), 40 mg/ml (lane 2), 80 mg/ml (lane 3), and
160 mg/ml (lane 4), followed by addition of CaCl2 and NaH2PO4
each to 3 mM and incubation in cell culture conditions for 1
month. Following incubation, the particles were pelleted as
described above and washed twice with DMEM. The pellet was
resuspended in 50 ml of 50 mM EDTA and 4 ml of each sample
was loaded in the lanes described above. For Fig. 8B, HSA-NLP
were prepared in a similar manner by using DMEM containing
HSA (Sigma) at 0.2 mg/ml (lane 1), 0.4 mg/ml (lane 2), 0.8 mg/
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were prepared similarly by using DMEM containing both proteins
at the concentrations mentioned above. Gel electrophoresis was
performed using a mini-gel system (Hoefer, Holliston, MA, USA).
The gels were stained with Coomassie blue as described earlier [2].
Protein Quantification
To quantify proteins, a standard curve was prepared by diluting
a stock solution of BSA (Sigma) in double-distilled water at various
concentrations varying from 10 to 50 mg/ml. Four volumes of
each protein solution were mixed with one volume of dye reagent
concentrate (Bio-Rad Laboratories) using a final volume of 1 ml of
solution. The solutions were mixed and the optical density was
monitored with a spectrophotometer (Molecular Devices) at a
wavelength of 595 nm. A ‘‘blank’’ solution containing only the dye
reagent diluted in double-distilled water as described above was
used to subtract the optical density seen without proteins. A graph
of optical density at 595 nm was plotted against the concentration
of proteins from the standards. The samples with unknown
concentration of proteins were processed the same way as the
standard solutions. The protein concentration of the unknown was
evaluated based on the optical density of the protein solutions and
interpolation from the graph prepared. The solutions of unknown
concentration were diluted until the optical density value obtained
was within the linear part of the graph. The values of proteins
mentioned represented average of experiments performed in
triplicates.
Preparation of Calcium Granules from Serum
Calcium granules were prepared as described earlier for serum
pellets [3]. Briefly, the granules shown in this study (labeled as
‘‘Calcium Granules’’) were prepared by adding sterile solutions of
either 0.25 M CaCl2 and/or 0.25 M Na2HPO4 (both at pH 7.4)
to FBS (2.5 ml) at final concentrations of either 48 mM CaCl2
(used for Figs. 9G, 10D, 12D, 13D, 14D, and 15G), 24 mM
Na2HPO4 (Figs. 9H, 10E, 12E, 13E, 14E, and 15H), or 2 mM of
both CaCl2 and Na2HPO4 (Figs. 9I, 10F, 12F, and 14F). Calcium
granules were also prepared in HS (2.5 ml) by diluting 2 mM of
both CaCl2 and Na2HPO4 (Figs. 13F and 15I). The ion solutions
were filtered through both 0.2-mm and 0.1-mm membranes prior
to use and were added in a drop-wise manner with vigorous
shaking in order to avoid spontaneous precipitation. Treated sera
were incubated at room temperature overnight, followed by
centrifugation at 16,0006 g for 1 hour, and washing steps using
HEPES buffer and the same centrifugation steps. The granules
were resuspended in 100 ml of HEPES buffer and were used for
the various microscopy and spectroscopy analyses.
Electron Microscopy
For scanning electron microscopy (SEM), washed particles,
calcium granules, and NB specimens were resuspended in double-
distilled water. A small aliquot of the sample was deposited on
formvar carbon-coated grids (Electron Microscopy Sciences, Fort
Washington, PA, USA). The excess liquid was removed with an
absorbent paper and the grids were dried overnight under a
laminar flow hood. Prior to observation, the specimens were
coated with gold for 90 sec. SEM observations were conducted
using a SEM S-5000 field-emission scanning electron microscope
(Hitachi Science Systems, Tokyo, Japan).
For transmission electron microscopy (TEM), washed particles
and NB samples were deposited on formvar carbon-coated grids
and were dried overnight as described above. All TEM
observations were performed without staining. Commercially
available calcium carbonate (CaCO3, A.C.S. grade reagent, purity
99.6%, Mallinckrodt Baker, Inc., Phillipsburg, NJ, USA), calcium
phosphate tribasic (Ca3(PO4)2, Kanto Chemical Co., Tokyo,
Japan) and HAP (buffered aqueous suspension, 25% solid, Sigma)
were diluted into DMEM or double-distilled water and processed
like the other samples as controls.
For thin-sections, washed particles and NB samples were
dehydrated with two washes of 100% ethanol. The samples were
incubated with Epon 812 resin (Electron Microscopy Sciences)
with gentle end-to-end agitation overnight at room temperature.
The samples were then centrifuged at 16,0006g for 15 min and
incubated at 72uC for 2 days to allow resin polymerization. Thin-
sections were prepared using a Leica Ultracut UCT microtome
(Leica Microsystems GmbH, Wetzlar, Germany). Thin-sections
were deposited on formvar carbon-coated grids. TEM observa-
tions and electron diffraction patterns were performed with a
JEOL JEM-1230 transmission electron microscope (JEOL, Tokyo,
Japan) operated at 120 keV.
Energy-Dispersive X-Ray Spectroscopy
Washed particles, calcium granules, and NB specimens were
resuspended in double-distilled water and deposited on formvar
carbon-coated grids. The grids were dried overnight in a laminar
flow hood. The samples were observed with a SEM S-3000N
scanning electron microscope (Hitachi Science Systems) and the
energy-dispersive X-ray spectroscopy (EDX) analysis was per-
formed using an EMAX Energy EX-400 EDX device (Horiba,
Tokyo, Japan). Each sample was irradiated for 30 sec and data
acquisition was performed with the EMAX software (Horiba) in
point mode analysis. Three different areas of each sample were
analyzed to ensure homogenous readings.
Nanoparticle Sizing by Dynamic Laser Scattering
Sizing of mineral nanoparticles was performed using DLS
according to established protocols [222,223]. Briefly, the particles
were prepared by adding calcium and phopshate ions into DMEM
(final volume of 1 ml) each at a concentration of 1 mM.
Alternatively, particles were also prepared by adding 1 mM of
calcium and phopshate ions each into DMEM containing 2 mg/
ml of either BSF (Sigma) or HSA (Sigma). The samples were
prepared directly in disposable plastic cuvettes and were shaken
vigorously prior to reading. Some samples were incubated for
various periods of time varying from 5 min to several days before
measurement. Measurements consisted of an average of 10
individual measurements taken at an interval of 10 sec. Each
measurement was performed in triplicates using the Malvern
Zetasizer Nano-Series (Malvern Instruments Ltd., Malvern,
Worcestershire, UK). A laser consisting of a helium-neon lamp
with a wavelength of 633 nm was used and the measurements
were performed at an angle of 90u from the sample.
Fourier-Transformed Infrared Spectroscopy
Washed and dried samples were mixed with potassium bromide
(Sigma) to obtain a ratio of 1:100 (w/w). The samples were
compressed with a hand press to form a thin transparent pellicle.
FTIR spectra were acquired with a Nicolet 5700 FTIR
spectrometer (Thermo Fisher Scientific, Waltham, MA, USA)
equipped with a deuterated triglycine sulfate (DTGS) detector.
The spectra were obtained at a resolution of 4 cm
21 and at
wavelengths ranging between 4,000 cm
21 to 400 cm
21. Each
spectrum represented an average of 32 consecutive scans. For
comparison, the commercially available controls of CaCO3,
Ca3(PO4)2, and HAP described earlier were diluted and washed
in either double-distilled water (shown in Fig. 13J, K, L,
respectively) or DMEM (data not shown), followed by processing
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signals and significant depressions/troughs that could not be
explained at this time.
Micro-Raman Spectroscopy
Aliquots of washed particles and NB samples were processed for
micro-Raman spectroscopy as described before [2]. Briefly, the
samples were resuspended in double-distilled water, deposited on
glass slides, and dried overnight. Micro-Raman spectra were
obtained using the inVia Raman confocal microscope (Renishaw,
Stonehouse, UK) equipped with a charge-coupled device (CCD)
detector. A laser beam of 633 nm operated at 17 mW was used as
the excitation source. Controls of CaCO3,C a 3(PO4)2, and HAP
were diluted and washed in either double-distilled water (shown in
Fig. 14J, K, L, respectively) or DMEM (data not shown), followed
by processing for micro-Raman analysis. In this case, the use of
DMEM produced increased carbonate signals for the Ca3(PO4)2
sample which may have originated from prolonged contact with
CO2 from air.
Powder X-Ray Diffraction Spectroscopy
X-ray diffraction spectroscopy was performed as described
earlier [2]. Briefly, washed particles and NB specimens were
deposited on glass slides and dried overnight. X-ray diffraction was
performed using a D5005 X-ray diffractometer (Bruker AXS,
Madison, WI, USA) with a source of X-ray consisting of a copper
tube operating at 40 kV. X-ray diffraction spectra were searched
against the database of the Joint Committee on Powder Diffraction
and Standards (JPCDS) in order to identify the chemical formula
of the crystalline compound under study.
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